Human	O
embryonic	O
stem	O
cells	O
(	O
hESCs	O
)	O
and	O
neural	O
progenitor	O
(	O
NP	O
)	O
cells	O
are	O
excellent	O
models	O
for	O
recapitulating	O
early	O
neuronal	O
development	O
in	O
vitro	O
,	O
and	O
are	O
key	O
to	O
establishing	O
strategies	O
for	O
the	O
treatment	O
of	O
degenerative	O
disorders	O
.	O

While	O
much	O
effort	O
had	O
been	O
undertaken	O
to	O
analyze	O
transcriptional	O
and	O
epigenetic	O
differences	O
during	O
the	O
transition	O
of	O
hESC	O
to	O
NP	O
,	O
very	O
little	O
work	O
has	O
been	O
performed	O
to	O
understand	O
post	O
-	O
transcriptional	O
changes	O
during	O
neuronal	O
differentiation	O
.	O

Alternative	O
RNA	O
splicing	O
(	O
AS	O
)	O
,	O
a	O
major	O
form	O
of	O
post	O
-	O
transcriptional	O
gene	O
regulation	O
,	O
is	O
important	O
in	O
mammalian	O
development	O
and	O
neuronal	O
function	O
.	O

Human	O
ESC	O
,	O
hESC	O
-	O
derived	O
NP	O
,	O
and	O
human	O
central	O
nervous	O
system	O
stem	O
cells	O
were	O
compared	O
using	O
Affymetrix	O
exon	O
arrays	O
.	O

We	O
introduced	O
an	O
outlier	O
detection	O
approach	O
,	O
REAP	O
(	O
Regression	O
-	O
based	O
Exon	O
Array	O
Protocol	O
)	O
,	O
to	O
identify	O
1,737	O
internal	O
exons	O
that	O
are	O
predicted	O
to	O
undergo	O
AS	O
in	O
NP	O
compared	O
to	O
hESC	O
.	O

Experimental	O
validation	O
of	O
REAP	O
-	O
predicted	O
AS	O
events	O
indicated	O
a	O
threshold	O
-	O
dependent	O
sensitivity	O
ranging	O
from	O
56	O
%	O
to	O
69	O
%	O
,	O
at	O
a	O
specificity	O
of	O
77	O
%	O
to	O
96	O
%	O
.	O

REAP	O
predictions	O
significantly	O
overlapped	O
sets	O
of	O
alternative	O
events	O
identified	O
using	O
expressed	O
sequence	O
tags	O
and	O
evolutionarily	O
conserved	O
AS	O
events	O
.	O

Our	O
results	O
also	O
reveal	O
that	O
focusing	O
on	O
differentially	O
expressed	O
genes	O
between	O
hESC	O
and	O
NP	O
will	O
overlook	O
14	O
%	O
of	O
potential	O
AS	O
genes	O
.	O

In	O
addition	O
,	O
we	O
found	O
that	O
REAP	O
predictions	O
are	O
enriched	O
in	O
genes	O
encoding	O
serine	B
/	I
threonine	I
kinase	I
and	O
helicase	B
activities	O
.	O

An	O
example	O
is	O
a	O
REAP	O
-	O
predicted	O
alternative	O
exon	O
in	O
the	O
SLK	B
(	O
serine	B
/	I
threonine	I
kinase	I
2	I
)	O
gene	O
that	O
is	O
differentially	O
included	O
in	O
hESC	O
,	O
but	O
skipped	O
in	O
NP	O
as	O
well	O
as	O
in	O
other	O
differentiated	O
tissues	O
.	O

Lastly	O
,	O
comparative	O
sequence	O
analysis	O
revealed	O
conserved	O
intronic	O
cis	O
-	O
regulatory	O
elements	O
such	O
as	O
the	O
FOX1	B
/	I
2	I
binding	O
site	O
GCAUG	O
as	O
being	O
proximal	O
to	O
candidate	O
AS	O
exons	O
,	O
suggesting	O
that	O
FOX1	B
/	I
2	I
may	O
participate	O
in	O
the	O
regulation	O
of	O
AS	O
in	O
NP	O
and	O
hESC	O
.	O

In	O
summary	O
,	O
a	O
new	O
methodology	O
for	O
exon	O
array	O
analysis	O
was	O
introduced	O
,	O
leading	O
to	O
new	O
insights	O
into	O
the	O
complexity	O
of	O
AS	O
in	O
human	O
embryonic	O
stem	O
cells	O
and	O
their	O
transition	O
to	O
neural	O
stem	O
cells	O
.	O

Author	O
SummaryDeriving	O
neural	O
progenitors	O
(	O
NP	O
)	O
from	O
human	O
embryonic	O
stem	O
cells	O
(	O
hESC	O
)	O
is	O
the	O
first	O
step	O
in	O
creating	O
homogeneous	O
populations	O
of	O
cells	O
that	O
will	O
differentiate	O
into	O
myriad	O
neuronal	O
subtypes	O
necessary	O
to	O
form	O
a	O
human	O
brain	O
.	O

During	O
alternative	O
RNA	O
splicing	O
(	O
AS	O
)	O
,	O
noncoding	O
sequences	O
(	O
introns	O
)	O
in	O
a	O
pre	O
-	O
mRNA	O
are	O
differentially	O
removed	O
in	O
different	O
cell	O
types	O
and	O
tissues	O
,	O
and	O
the	O
remaining	O
sequences	O
(	O
exons	O
)	O
are	O
joined	O
to	O
form	O
multiple	O
forms	O
of	O
mature	O
RNA	O
,	O
playing	O
an	O
important	O
role	O
in	O
cellular	O
diversity	O
.	O

The	O
authors	O
utilized	O
Affymetrix	O
exon	O
arrays	O
with	O
probes	O
targeting	O
hundreds	O
of	O
thousands	O
of	O
exons	O
to	O
study	O
AS	O
comparing	O
human	O
ES	O
to	O
NP	O
.	O

To	O
accomplish	O
this	O
,	O
a	O
novel	O
computational	O
method	O
,	O
REAP	O
(	O
Regression	O
-	O
based	O
Exon	O
Array	O
Protocol	O
)	O
,	O
is	O
introduced	O
to	O
analyze	O
the	O
exon	O
array	O
data	O
.	O

The	O
authors	O
showed	O
that	O
REAP	O
candidates	O
are	O
consistent	O
with	O
other	O
types	O
of	O
methods	O
for	O
discovering	O
alternative	O
exons	O
.	O

In	O
addition	O
,	O
REAP	O
candidate	O
alternative	O
exons	O
are	O
enriched	O
in	O
genes	O
encoding	O
serine	B
/	I
theronine	I
kinases	I
and	O
helicase	B
activities	O
.	O

An	O
example	O
is	O
the	O
alternative	O
exon	O
in	O
the	O
SLK	B
(	O
serine	B
/	I
threonine	I
kinase	I
2	I
)	O
gene	O
that	O
is	O
included	O
in	O
hESC	O
,	O
but	O
excluded	O
in	O
NP	O
as	O
well	O
as	O
in	O
other	O
differentiated	O
tissues	O
.	O

Finally	O
,	O
by	O
comparing	O
genomic	O
sequences	O
across	O
multiple	O
mammals	O
,	O
the	O
authors	O
identified	O
dozens	O
of	O
conserved	O
candidate	O
binding	O
sites	O
that	O
were	O
enriched	O
proximal	O
to	O
REAP	O
candidate	O
exons	O
.	O

The	O
human	O
central	O
nervous	O
system	O
is	O
composed	O
of	O
thousands	O
of	O
neuronal	O
subtypes	O
originating	O
from	O
neural	O
stem	O
cells	O
(	O
NSCs	O
)	O
that	O
migrate	O
from	O
the	O
developing	O
neural	O
tube	O
.	O

Such	O
neuronal	O
complexity	O
is	O
generated	O
by	O
a	O
vast	O
repertoire	O
of	O
molecular	O
,	O
genetic	O
,	O
and	O
epigenetic	O
mechanisms	O
,	O
such	O
as	O
the	O
active	O
retrotransposition	O
of	O
transposable	O
elements	O
[	O
1	O
]	O
,	O
alternative	O
promoter	O
usage	O
,	O
alternative	O
RNA	O
splicing	O
(	O
AS	O
)	O
,	O
alternative	O
polyadenylation	O
,	O
RNA	O
editing	O
,	O
post	O
-	O
translational	O
modifications	O
,	O
and	O
epigenetic	O
modulation	O
[	O
2	O
]	O
.	O

Understanding	O
the	O
processes	O
that	O
generate	O
neuronal	O
diversity	O
is	O
key	O
to	O
gaining	O
insights	O
into	O
neuronal	O
development	O
and	O
paving	O
new	O
avenues	O
for	O
biomedical	O
research	O
.	O

Human	O
embryonic	O
stem	O
cells	O
(	O
hESCs	O
)	O
are	O
pluripotent	O
cells	O
that	O
propagate	O
perpetually	O
in	O
culture	O
as	O
undifferentiated	O
cells	O
and	O
can	O
be	O
induced	O
to	O
differentiate	O
into	O
a	O
multitude	O
of	O
cell	O
types	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O
[	O
3	O
]	O
.	O

As	O
hESCs	O
can	O
theoretically	O
generate	O
all	O
cell	O
types	O
that	O
make	O
up	O
an	O
organism	O
,	O
they	O
serve	O
as	O
an	O
important	O
model	O
for	O
understanding	O
early	O
human	O
embryonic	O
development	O
.	O

In	O
addition	O
,	O
the	O
hESCs	O
are	O
a	O
nearly	O
infinite	O
source	O
for	O
generating	O
specialized	O
cells	O
such	O
as	O
neurons	O
and	O
glia	O
for	O
potential	O
therapeutic	O
purposes	O
[	O
4,5	O
]	O
.	O

In	O
recent	O
years	O
,	O
methods	O
have	O
been	O
introduced	O
to	O
induce	O
hESCs	O
to	O
differentiate	O
into	O
neural	O
progenitors	O
(	O
NPs	O
)	O
[	O
6,7	O
]	O
and	O
neuronal	O
and	O
glial	O
subtypes	O
[	O
8–12	O
]	O
.	O

The	O
therapeutic	O
interest	O
in	O
understanding	O
the	O
molecular	O
basis	O
of	O
pluripotency	O
and	O
differentiation	O
has	O
led	O
to	O
many	O
studies	O
comparing	O
transcriptional	O
profiles	O
in	O
different	O
hESC	O
lines	O
and	O
the	O
study	O
of	O
expression	O
changes	O
during	O
the	O
differentiation	O
of	O
hESCs	O
to	O
various	O
lineages	O
[	O
13–17	O
]	O
.	O

NSCs	O
and	O
progenitor	O
cells	O
(	O
NPs	O
)	O
are	O
present	O
throughout	O
development	O
and	O
persist	O
into	O
adulthood	O
[	O
18–20	O
]	O
.	O

They	O
are	O
critical	O
for	O
both	O
basic	O
research	O
and	O
developing	O
approaches	O
to	O
treat	O
neurological	O
disorders	O
,	O
such	O
as	O
Parkinson	O
disease	O
and	O
amyotrophic	O
lateral	O
sclerosis	O
(	O
ALS	O
)	O
,	O
and	O
stroke	O
or	O
head	O
injuries	O
[	O
21,22	O
]	O
.	O

NSCs	O
and	O
NPCs	O
can	O
be	O
isolated	O
from	O
human	O
fetal	O
brain	O
tissue	O
[	O
23–26	O
]	O
,	O
as	O
well	O
as	O
from	O
several	O
regions	O
of	O
the	O
adult	O
human	O
brain	O
,	O
such	O
as	O
the	O
cortex	O
,	O
hippocampus	O
,	O
and	O
the	O
subventricular	O
zone	O
(	O
SVZ	O
)	O
of	O
the	O
lateral	O
ventricles	O
[	O
26–35	O
]	O
.	O

Several	O
studies	O
have	O
explored	O
expression	O
patterns	O
of	O
NPCs	O
.	O

For	O
example	O
,	O
Wright	O
et	O
al.	O
identified	O
""""	O
expressed	O
""""	O
and	O
""""	O
not	O
expressed	O
""""	O
genes	O
in	O
NPCs	O
isolated	O
from	O
the	O
human	O
embryonic	O
cortex	O
[	O
24	O
]	O
;	O
Cai	O
et	O
al.	O
used	O
the	O
massively	O
parallel	O
signature	O
sequencing	O
profiling	O
(	O
MPSS	O
)	O
technique	O
to	O
analyze	O
expression	O
of	O
fetal	O
NPCs	O
in	O
comparison	O
to	O
hESCs	O
and	O
astrocyte	O
precursors	O
[	O
27	O
]	O
;	O
Maisel	O
et	O
al.	O
used	O
Affymetrix	O
Gene	O
Chip	O
arrays	O
to	O
compare	O
adult	O
and	O
fetal	O
NPCs	O
propagated	O
in	O
neurospheres	O
[	O
35	O
]	O
.	O

However	O
,	O
as	O
with	O
hESCs	O
,	O
the	O
focus	O
thus	O
far	O
has	O
been	O
primarily	O
on	O
transcriptional	O
differences	O
,	O
which	O
ignores	O
differential	O
RNA	O
processing	O
such	O
as	O
AS	O
,	O
polyadenylation	O
,	O
degradation	O
,	O
or	O
promoter	O
usage	O
.	O

AS	O
is	O
frequently	O
used	O
to	O
regulate	O
gene	O
expression	O
and	O
to	O
generate	O
tissue	O
-	O
specific	O
mRNA	O
and	O
protein	O
isoforms	O
[	O
36–39	O
]	O
.	O

Recent	O
studies	O
using	O
splicing	O
-	O
sensitive	O
microarrays	O
suggested	O
that	O
up	O
to	O
75	O
%	O
of	O
human	O
genes	O
undergo	O
AS	O
,	O
where	O
multiple	O
isoforms	O
are	O
derived	O
from	O
the	O
same	O
genetic	O
loci	O
[	O
40	O
]	O
.	O

This	O
functional	O
complexity	O
underscores	O
the	O
challenge	O
and	O
importance	O
of	O
elucidating	O
AS	O
regulation	O
.	O

AS	O
appears	O
to	O
play	O
a	O
dominant	O
role	O
in	O
regulating	O
neuronal	O
gene	O
expression	O
and	O
function	O
[	O
41,42	O
]	O
.	O

Examples	O
of	O
splicing	O
regulators	O
that	O
are	O
enriched	O
and	O
function	O
specifically	O
in	O
neuronal	O
cells	O
include	O
the	O
brain	B
-	I
specific	I
splicing	I
factor	I
Nova	I
[	O
43,44	O
]	O
and	O
neural	B
-	I
specific	I
polypyrimidine	I
tract	I
binding	I
protein	I
(	O
nPTB	B
)	O
,	O
which	O
antagonizes	O
its	O
paralogous	O
PTB	O
to	O
regulate	O
exon	O
exclusion	O
in	O
neuronal	O
cells	O
[	O
45–47	O
]	O
.	O

Finally	O
,	O
an	O
early	O
report	O
estimating	O
that	O
15	O
%	O
of	O
point	O
mutations	O
disrupt	O
splicing	O
underscores	O
the	O
importance	O
of	O
splicing	O
in	O
human	O
disease	O
[	O
48	O
]	O
.	O

Indeed	O
,	O
the	O
disruption	O
of	O
specific	O
AS	O
events	O
has	O
been	O
implicated	O
in	O
several	O
human	O
genetic	O
diseases	O
,	O
such	O
as	O
frontotemporal	O
dementia	O
and	O
parkinsonism	O
,	O
Frasier	O
syndrome	O
,	O
and	O
atypical	O
cystic	O
fibrosis	O
[	O
49	O
]	O
.	O

While	O
insights	O
into	O
the	O
regulation	O
of	O
AS	O
have	O
come	O
predominantly	O
from	O
the	O
molecular	O
dissection	O
of	O
individual	O
genes	O
[	O
36,49	O
]	O
,	O
it	O
is	O
becoming	O
clear	O
that	O
molecular	O
rules	O
can	O
be	O
identified	O
from	O
large	O
-	O
scale	O
studies	O
of	O
both	O
constitutive	O
splicing	O
and	O
AS	O
[	O
40	O
]	O
.	O

Most	O
systematic	O
global	O
analyses	O
on	O
AS	O
have	O
focused	O
on	O
comparisons	O
across	O
differentiated	O
human	O
tissues	O
[	O
50–52	O
]	O
.	O

Only	O
one	O
study	O
,	O
utilizing	O
expressed	O
sequence	O
tag	O
(	O
EST	O
)	O
collections	O
from	O
stem	O
cells	O
,	O
has	O
attempted	O
to	O
find	O
AS	O
differences	O
between	O
embryonic	O
and	O
hematopoietic	O
stem	O
cells	O
[	O
53	O
]	O
.	O

However	O
,	O
utilizing	O
ESTs	O
to	O
identify	O
AS	O
has	O
intrinsic	O
problems	O
,	O
as	O
ESTs	O
tend	O
to	O
be	O
biased	O
for	O
the	O
3′	O
ends	O
of	O
genes	O
,	O
and	O
full	O
coverage	O
of	O
the	O
genome	O
by	O
ESTs	O
is	O
severely	O
limited	O
by	O
sequencing	O
costs	O
.	O

The	O
commercial	O
availability	O
of	O
Affymetrix	O
exon	O
arrays	O
provides	O
an	O
alternative	O
approach	O
to	O
interrogate	O
the	O
expression	O
of	O
every	O
known	O
and	O
predicted	O
exon	O
in	O
the	O
human	O
genome	O
.	O

The	O
Affymetrix	O
GeneChip	O
Human	O
Exon	O
1.0	O
ST	O
array	O
contains	O
∼5.4	O
million	O
features	O
used	O
to	O
interrogate	O
∼1	O
million	O
exon	O
clusters	O
(	O
collections	O
of	O
overlapping	O
)	O
of	O
known	O
and	O
predicted	O
exons	O
with	O
more	O
than	O
1.4	O
million	O
probesets	O
,	O
with	O
an	O
average	O
of	O
four	O
probes	O
per	O
exon	O
.	O

Our	O
goal	O
was	O
to	O
identify	O
and	O
characterize	O
AS	O
events	O
that	O
distinguish	O
pluripotent	O
hESCs	O
from	O
multipotent	O
NPs	O
,	O
paving	O
the	O
way	O
for	O
future	O
candidate	O
gene	O
approaches	O
to	O
study	O
the	O
impact	O
of	O
AS	O
in	O
hESCs	O
and	O
NPs	O
.	O

However	O
,	O
as	O
different	O
hESC	O
lines	O
were	O
established	O
under	O
different	O
culture	O
conditions	O
from	O
embryos	O
with	O
unique	O
genetic	O
backgrounds	O
,	O
we	O
expected	O
that	O
hESCs	O
and	O
their	O
derived	O
NPs	O
might	O
have	O
distinct	O
epigenetic	O
and	O
molecular	O
signatures	O
[	O
54	O
]	O
.	O

As	O
both	O
common	O
and	O
cell	O
-	O
line	O
specific	O
alternatively	O
spliced	O
exons	O
are	O
likely	O
to	O
be	O
important	O
in	O
regenerative	O
research	O
,	O
in	O
our	O
study	O
two	O
separate	O
hESC	O
lines	O
were	O
used	O
,	O
with	O
independent	O
protocols	O
for	O
differentiating	O
the	O
hESCs	O
into	O
NPs	O
positive	O
for	O
Sox1	B
,	O
an	O
early	O
neuroectodermal	O
marker	O
.	O

As	O
an	O
endogenously	O
occurring	O
population	O
of	O
NPs	O
,	O
human	O
central	O
nervous	O
system	O
stem	O
cells	O
grown	O
as	O
neurospheres	O
(	O
hCNS	O
-	O
SCns	O
)	O
were	O
utilized	O
as	O
a	O
natural	O
benchmark	O
for	O
derived	O
NPs	O
.	O

We	O
developed	O
an	O
approach	O
called	O
REAP	O
(	O
Regression	O
-	O
based	O
Exon	O
Array	O
Protocol	O
)	O
,	O
which	O
is	O
based	O
on	O
robust	O
regression	O
that	O
analyzed	O
signal	O
estimates	O
from	O
Affymetrix	O
exon	O
array	O
data	O
to	O
identify	O
AS	O
exons	O
.	O

Experimental	O
validation	O
revealed	O
alternative	O
exons	O
that	O
distinguish	O
hESCs	O
from	O
NPs	O
;	O
some	O
of	O
them	O
also	O
distinguish	O
hESCs	O
from	O
a	O
variety	O
of	O
differentiated	O
tissues	O
.	O

A	O
comparison	O
of	O
REAP	O
-	O
predicted	O
alternative	O
events	O
with	O
independent	O
methods	O
,	O
such	O
as	O
using	O
publicly	O
available	O
transcripts	O
(	O
ESTs	O
and	O
mRNAs	O
)	O
and	O
computational	O
predictions	O
based	O
on	O
genomic	O
sequence	O
information	O
alone	O
[	O
55	O
]	O
,	O
showed	O
a	O
strong	O
concordance	O
of	O
REAP	O
-	O
identified	O
AS	O
exons	O
with	O
AS	O
events	O
identified	O
from	O
these	O
orthogonal	O
methods	O
.	O

Finally	O
,	O
using	O
analysis	O
of	O
the	O
sequences	O
flanking	O
REAP	O
-	O
identified	O
alternative	O
exons	O
,	O
we	O
were	O
able	O
to	O
discover	O
known	O
and	O
novel	O
cis	O
-	O
regulatory	O
elements	O
that	O
potentially	O
regulate	O
these	O
AS	O
events	O
.	O

Derivation	O
of	O
Neural	O
Progenitors	O
from	O
Embryonic	O
Stem	O
CellsNPs	O
were	O
independently	O
derived	O
from	O
two	O
hESC	O
lines	O
,	O
and	O
RNA	O
extracted	O
from	O
the	O
cell	O
lines	O
was	O
processed	O
and	O
hybridized	O
onto	O
Affymetrix	O
Human	O
1.0	O
ST	O
exon	O
arrays	O
.	O

Immunohistochemical	O
and	O
reverse	O
-	O
transcriptase	B
polymerase	B
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
analyses	O
demonstrated	O
that	O
the	O
hESCs	O
expressed	O
pluripotent	O
marker	O
genes	O
,	O
and	O
the	O
derived	O
NPs	O
expressed	O
multipotent	O
and	O
neurogenic	O
markers	O
similar	O
to	O
hCNS	O
-	O
SCns	O
.	O

Undifferentiated	O
Cythera	O
(	O
Cyt	O
-	O
ES	O
)	O
and	O
HUES6	O
(	O
HUES6-ES	O
)	O
hESC	O
lines	O
were	O
maintained	O
in	O
culture	O
as	O
previously	O
described	O
[	O
12,23,56	O
]	O
.	O

Utilizing	O
specific	O
antibodies	O
,	O
we	O
observed	O
that	O
undifferentiated	O
Cyt	O
-	O
ES	O
and	O
HUES6-ES	O
cells	O
were	O
positive	O
for	O
the	O
pluripotent	O
markers	O
Oct4	B
,	O
SSEA-4	B
,	O
and	O
Tra-1–80	B
(	O
unpublished	O
data	O
)	O
.	O

NPs	O
were	O
derived	O
from	O
the	O
hESC	O
cell	O
lines	O
using	O
protocols	O
optimized	O
for	O
each	O
line	O
(	O
see	O
Materials	O
and	O
Methods	O
)	O
.	O

Greater	O
than	O
90	O
%	O
of	O
derived	O
NP	O
cells	O
(	O
Cyt	O
-	O
NP	O
from	O
Cyt	O
-	O
ES	O
and	O
HUES6-NP	O
from	O
HUES6-ES	O
)	O
were	O
positive	O
for	O
Sox1	B
,	O
an	O
early	O
neuroectodermal	O
marker	O
,	O
and	O
Nestin	B
(	O
Figure	O
1A	O
)	O
,	O
and	O
negative	O
for	O
Oct4	B
(	O
unpublished	O
data	O
)	O
.	O

As	O
a	O
natural	O
benchmark	O
for	O
the	O
derived	O
NPs	O
,	O
we	O
utilized	O
hCNS	O
-	O
SCns	O
,	O
which	O
were	O
previously	O
isolated	O
from	O
fresh	O
human	O
fetal	O
brain	O
tissues	O
using	O
antibodies	O
to	O
cell	O
-	O
surface	O
markers	O
and	O
fluorescence	O
-	O
activated	O
cell	O
sorting	O
[	O
12,23	O
]	O
.	O

The	O
hCNS	O
-	O
SCns	O
form	O
neurospheres	O
in	O
culture	O
which	O
are	O
greater	O
than	O
90	O
%	O
Nestin	B
and	O
Sox1	B
positive	O
,	O
and	O
differentiate	O
into	O
both	O
neurons	O
and	O
glial	O
cells	O
in	O
vitro	O
[	O
12,23	O
]	O
.	O

Immunohistochemical	O
analysis	O
confirmed	O
that	O
hCNS	O
-	O
SCns	O
were	O
negative	O
for	O
Oct4	B
(	O
unpublished	O
data	O
)	O
and	O
positive	O
for	O
Sox1	B
and	O
Nestin	B
(	O
Figure	O
1A	O
)	O
.Figure	O
1Molecular	O
Characterization	O
of	O
Human	O
Embryonic	O
Stem	O
Cell	O
Lines	O
and	O
Neuronal	O
Progenitors	O
(	O
A	O
)	O
Immunohistochemical	O
analysis	O
of	O
markers	O
in	O
NPs	O
derived	O
from	O
the	O
hESC	O
lines	O
(	O
Cyt	O
-	O
NP	O
from	O
Cyt	O
-	O
ES	O
;	O
and	O
HUES6-NP	O
from	O
HUES6-ES	O
)	O
and	O
in	O
hCNS	O
-	O
SCns	O
.	O

Cyt	O
-	O
NP	O
,	O
HUES6-NP	O
,	O
and	O
hCNS	O
-	O
SCns	O
cells	O
were	O
Nestin	B
and	O
Sox1	B
positive	O
.	O

Nuclei	O
stained	O
positive	O
for	O
Dapi	O
.	O

White	O
horizontal	O
bar	O
indicated	O
15	O
μm.	O
(	O
B	O
)	O
Gene	O
-	O
level	O
signal	O
estimates	O
of	O
marker	O
genes	O
(	O
GAPDH	B
,	O
Oct4	B
,	O
Nanog	B
,	O
Nestin	B
,	O
Notch1	B
,	O
DNER	B
,	O
and	O
Sox1	B
)	O
from	O
Affymetrix	O
exon	O
array	O
analysis	O
.	O

Vertical	O
bars	O
indicated	O
average	O
log2	O
normalized	O
signal	O
estimates	O
,	O
and	O
error	O
bars	O
represented	O
standard	O
deviations	O
from	O
three	O
independent	O
replicate	O
experiments	O
per	O
cell	O
type.	O
(	O
C	O
)	O
RT	O
-	O
PCR	O
of	O
marker	O
genes	O
(	O
GAPDH	B
,	O
Oct4	B
,	O
Nanog	B
,	O
Nestin	B
,	O
Notch1	B
,	O
DNER	B
,	O
and	O
Sox1	B
)	O
.Here	O
,	O
known	O
molecular	O
markers	O
were	O
subjected	O
to	O
RT	O
-	O
PCR	O
measurements	O
,	O
which	O
were	O
compared	O
to	O
gene	O
-	O
level	O
signal	O
estimates	O
generated	O
from	O
the	O
exon	O
array	O
data	O
.	O

Total	O
RNA	O
was	O
extracted	O
,	O
and	O
labeled	O
cDNA	O
targets	O
were	O
generated	O
from	O
three	O
independent	O
preparations	O
of	O
each	O
cell	O
type	O
,	O
namely	O
Cyt	O
-	O
ES	O
,	O
HUES6-ES	O
,	O
Cyt	O
-	O
NP	O
,	O
HUES6-NP	O
,	O
and	O
hCNS	O
-	O
SCns	O
.	O

To	O
facilitate	O
downstream	O
analyses	O
,	O
instead	O
of	O
utilizing	O
the	O
meta	O
-	O
gene	O
sets	O
available	O
from	O
the	O
manufacturers	O
,	O
we	O
generated	O
our	O
own	O
gene	O
models	O
by	O
clustering	O
alignments	O
of	O
ESTs	O
and	O
mRNAs	O
to	O
annotated	O
known	O
genes	O
from	O
the	O
University	O
of	O
California	O
Santa	O
Cruz	O
(	O
UCSC	O
)	O
Genome	O
Browser	O
Database	O
.	O

After	O
hybridization	O
,	O
scanning	O
,	O
and	O
extraction	O
of	O
signal	O
estimates	O
for	O
each	O
probeset	O
on	O
the	O
exon	O
arrays	O
,	O
gene	O
-	O
level	O
estimates	O
were	O
computed	O
based	O
on	O
our	O
gene	O
models	O
using	O
available	O
normalization	O
and	O
signal	O
estimation	O
software	O
from	O
Affymetrix	O
.	O

For	O
every	O
gene	O
,	O
a	O
t	O
-	O
statistic	O
and	O
corresponding	O
p	O
-	O
value	O
were	O
computed	O
representing	O
the	O
relative	O
enrichment	O
of	O
the	O
expression	O
of	O
the	O
gene	O
in	O
hESC	O
versus	O
NP	O
,	O
such	O
as	O
in	O
Cyt	O
-	O
ES	O
versus	O
Cyt	O
-	O
NP	O
.	O

After	O
correcting	O
for	O
multiple	O
hypothesis	O
testing	O
using	O
the	O
Benjamini	O
-	O
Hochberg	O
method	O
,	O
a	O
p	O
-	O
value	O
cutoff	O
of	O
0.01	O
was	O
used	O
to	O
identify	O
enriched	O
genes	O
.	O

Close	O
inspection	O
of	O
all	O
pairs	O
of	O
hESC	O
-	O
NP	O
comparisons	O
revealed	O
a	O
generally	O
significant	O
overlap	O
from	O
31	O
%	O
to	O
85	O
%	O
of	O
the	O
smaller	O
of	O
two	O
compared	O
sets	O
of	O
enriched	O
genes	O
(	O
see	O
Figure	O
S1	O
)	O
.	O

Thus	O
for	O
the	O
purpose	O
of	O
identifying	O
overall	O
pluripotent	O
and	O
neural	O
lineage	O
-	O
specific	O
genes	O
,	O
the	O
collective	O
set	O
of	O
NPs	O
(	O
Cyt	O
-	O
NP	O
,	O
HUES6-NP	O
,	O
and	O
hCNS	O
-	O
SCns	O
)	O
was	O
compared	O
to	O
the	O
collective	O
set	O
of	O
hESCs	O
(	O
Cyt	O
-	O
ES	O
and	O
HUES6-ES	O
)	O
.Oct4	O
and	O
Nanog	B
,	O
which	O
are	O
important	O
in	O
maintaining	O
the	O
pluripotent	O
state	O
of	O
embryonic	O
stem	O
cells	O
(	O
ESCs	O
)	O
,	O
were	O
highly	O
expressed	O
in	O
hESCs	O
but	O
were	O
significantly	O
lower	O
in	O
NPs	O
(	O
Figure	O
1B	O
)	O
.	O

RT	O
-	O
PCR	O
of	O
Oct4	B
and	O
Nanog	B
mRNA	O
levels	O
accurately	O
reflected	O
the	O
signal	O
estimates	O
from	O
the	O
array	O
(	O
Figure	O
1C	O
)	O
.	O

Interestingly	O
,	O
Nestin	B
was	O
not	O
significantly	O
higher	O
in	O
NPs	O
as	O
compared	O
to	O
the	O
hESC	O
from	O
the	O
gene	O
-	O
level	O
estimates	O
(	O
p	O
-	O
value	O
0.065	O
)	O
,	O
which	O
was	O
further	O
confirmed	O
by	O
RT	O
-	O
PCR	O
(	O
Figure	O
1C	O
)	O
.	O

Notch	B
was	O
recently	O
identified	O
to	O
be	O
important	O
in	O
promoting	O
the	O
neural	O
lineage	O
entry	O
in	O
mouse	O
ESCs	O
[	O
57	O
]	O
and	O
was	O
shown	O
to	O
regulate	O
stem	O
cell	O
proliferation	O
in	O
somatic	O
mouse	O
and	O
hESC	O
[	O
58	O
]	O
.	O

Gene	O
-	O
level	O
signal	O
estimates	O
suggested	O
that	O
Notch	B
was	O
significantly	O
higher	O
in	O
hCNS	O
-	O
SCns	O
relative	O
to	O
hESCs	O
,	O
but	O
levels	O
of	O
Notch	B
were	O
not	O
significantly	O
different	O
in	O
the	O
derived	O
NPs	O
compared	O
to	O
hESCs	O
.	O

Delta	B
/	I
Notch	I
-	I
like	I
EGF	I
-	I
related	I
receptor	I
(	O
DNER	B
)	O
,	O
a	O
neuron	O
-	O
specific	O
transmembrane	O
protein	O
,	O
was	O
recently	O
shown	O
to	O
bind	O
to	O
Notch	B
at	O
cell	O
–	O
cell	O
contacts	O
and	O
activates	O
Notch	B
signaling	O
in	O
vitro	O
[	O
59	O
]	O
.	O

RT	O
-	O
PCR	O
validation	O
of	O
DNER	B
confirmed	O
array	O
-	O
derived	O
signal	O
estimates	O
,	O
indicating	O
an	O
enrichment	O
of	O
DNER	B
in	O
NPs	O
relative	O
to	O
hESCs	O
(	O
Figure	O
1C	O
)	O
.	O

Finally	O
,	O
Sox1	B
,	O
a	O
HMG	B
-	I
box	I
protein	I
related	O
to	O
SRY	B
,	O
was	O
shown	O
to	O
be	O
one	O
of	O
the	O
earliest	O
transcription	O
factors	O
expressed	O
in	O
cells	O
committed	O
to	O
the	O
neural	O
fate	O
[	O
60	O
]	O
.	O

Here	O
the	O
gene	O
-	O
level	O
estimates	O
indicated	O
that	O
Sox1	B
was	O
expressed	O
significantly	O
higher	O
in	O
NPs	O
relative	O
to	O
hESCs	O
(	O
p	O
-	O
value	O
0.00013	O
,	O
Figure	O
1B	O
)	O
,	O
a	O
finding	O
that	O
was	O
confirmed	O
by	O
RT	O
-	O
PCR	O
(	O
Figure	O
1C	O
)	O
.From	O
these	O
examples	O
,	O
we	O
concluded	O
that	O
RT	O
-	O
PCR	O
validation	O
correlated	O
well	O
with	O
gene	O
-	O
level	O
estimates	O
from	O
the	O
exon	O
array	O
.	O

In	O
addition	O
,	O
the	O
derived	O
NPs	O
had	O
decreased	O
levels	O
of	O
pluripotent	O
markers	O
Oct4	B
and	O
Nanog	B
but	O
had	O
levels	O
of	O
Sox1	B
that	O
were	O
comparable	O
to	O
hCNS	O
-	O
SCns	O
.	O

This	O
finding	O
confirmed	O
that	O
the	O
derived	O
NPs	O
were	O
committed	O
to	O
a	O
neural	O
fate	O
and	O
validated	O
the	O
use	O
of	O
hCNS	O
-	O
SCns	O
as	O
a	O
benchmark	O
for	O
NPs	O
.	O

Next	O
we	O
asked	O
whether	O
the	O
highest	O
enriched	O
genes	O
in	O
hESCs	O
relative	O
to	O
NPs	O
reflected	O
our	O
existing	O
knowledge	O
in	O
the	O
literature	O
.	O

Using	O
the	O
above	O
-	O
mentioned	O
groupings	O
of	O
hESCs	O
(	O
Cyt	O
-	O
ES	O
,	O
HUES6-ES	O
)	O
and	O
NPs	O
(	O
Cyt	O
-	O
NP	O
,	O
HUES6-NP	O
,	O
and	O
hCNS	O
-	O
SCns	O
)	O
,	O
2,945	O
genes	O
were	O
enriched	O
in	O
hESCs	O
relative	O
to	O
NPs	O
;	O
and	O
552	O
genes	O
were	O
enriched	O
in	O
the	O
NPs	O
relative	O
to	O
hESCs	O
,	O
at	O
a	O
p	O
-	O
value	O
significance	O
cutoff	O
of	O
0.01	O
(	O
correcting	O
for	O
multiple	O
hypothesis	O
testing	O
using	O
the	O
Benjamini	O
-	O
Hochberg	O
method	O
)	O
.	O

The	O
15	O
most	O
enriched	O
genes	O
in	O
hESCs	O
included	O
genes	O
such	O
as	O
teratocarcinoma	B
-	I
derived	I
growth	I
factor	I
1	I
(	O
TDGF1	B
/	B
cripto	I
;	O
p	O
-	O
value	O
<	O
10−12	O
)	O
,	O
zinc	B
finger	I
protein	I
42	I
(	O
Zfp42	B
/	O
Rex1	B
;	O
p	O
-	O
value	O
<	O
10−12	O
)	O
,	O
Oct4	B
(	O
p	O
-	O
value	O
<	O
10−12	O
)	O
,	O
Nanog	B
(	O
p	O
-	O
value	O
<	O
10−10	O
)	O
,	O
lin-28	B
homolog	I
(	O
p	O
-	O
value	O
<	O
10−10	O
)	O
,	O
cadherin	B
1	I
preprotein	I
(	O
p	O
-	O
value	O
<	O
10−10	O
)	O
,	O
claudin	B
6	I
(	O
p	O
-	O
value	O
<	O
10−9	O
)	O
,	O
ephrin	O
receptor	O
EphA1	B
(	O
p	O
-	O
value	O
<	O
10−9	O
)	O
,	O
and	O
erbB3	B
(	O
p	O
-	O
value	O
<	O
10−9	O
)	O
.	O

TDGF1	B
/	B
cripto	I
was	O
first	O
shown	O
to	O
stimulate	O
DNA	O
synthesis	O
and	O
cell	O
proliferation	O
of	O
both	O
undifferentiated	O
and	O
differentiated	O
embryonic	O
carcinoma	O
cells	O
[	O
61	O
]	O
and	O
was	O
later	O
shown	O
to	O
be	O
important	O
for	O
cardiomyocyte	O
formation	O
from	O
mouse	O
ESC	O
[	O
62	O
]	O
.	O

Oct4	B
,	O
reviewed	O
in	O
[	O
63	O
]	O
,	O
and	O
Nanog	B
[	O
64	O
]	O
are	O
crucial	O
for	O
the	O
pluripotency	O
of	O
hESCs	O
.	O

Recently	O
,	O
knockdown	O
of	O
Zfp42	B
/	O
Rex-1	B
in	O
mouse	O
ESC	O
caused	O
the	O
cells	O
to	O
differentiate	O
[	O
65	O
]	O
.	O

Our	O
gene	O
-	O
level	O
exon	O
array	O
analysis	O
confirmed	O
that	O
the	O
hESCs	O
and	O
NPs	O
were	O
molecularly	O
distinct	O
.	O

To	O
reveal	O
global	O
functional	O
differences	O
between	O
the	O
enriched	O
genes	O
in	O
hESCs	O
or	O
NPs	O
,	O
the	O
enriched	O
genes	O
were	O
subjected	O
to	O
a	O
Gene	O
Ontology	O
(	O
GO	O
,	O
http://www.geneontology.org	O
)	O
analysis	O
as	O
described	O
previously	O
[	O
55	O
]	O
.	O

Enriched	O
genes	O
in	O
hESCs	O
were	O
more	O
likely	O
to	O
be	O
in	O
molecular	O
function	O
categories	O
,	O
such	O
as	O
""""	O
RNA	O
binding	O
""""	O
(	O
p	O
-	O
value	O
<	O
10−12	O
)	O
,	O
""""	O
structural	O
constituent	O
of	O
ribosome	O
""""	O
(	O
p	O
-	O
value	O
<	O
10−51	O
)	O
,	O
""""	O
exonuclease	O
activity	O
""""	O
(	O
p	O
-	O
value	O
<	O
10−6	O
)	O
,	O
""""	O
cytochrome	O
-	O
c	O
oxidase	O
activity	O
""""	O
(	O
p	O
-	O
value	O
<	O
10−5	O
)	O
,	O
and	O
""""	O
ATP	O
binding	O
""""	O
(	O
p	O
-	O
value	O
<	O
10−6	O
)	O
,	O
and	O
in	O
biological	O
processes	O
involved	O
with	O
""""	O
tRNA	O
processing	O
""""	O
(	O
p	O
-	O
value	O
<	O
10−6	O
)	O
and	O
""""	O
protein	O
biosynthesis	O
""""	O
(	O
p	O
-	O
value	O
<	O
10−48	O
)	O
,	O
consistent	O
with	O
our	O
knowledge	O
of	O
hESCs	O
as	O
a	O
rapidly	O
proliferating	O
population	O
of	O
cells	O
(	O
Figure	O
2A	O
)	O
.	O

Similar	O
analysis	O
of	O
the	O
enriched	O
genes	O
in	O
NPs	O
revealed	O
an	O
overrepresentation	O
in	O
molecular	O
functional	O
categories	O
,	O
such	O
as	O
""""	O
calcium	O
ion	O
binding	O
""""	O
(	O
p	O
-	O
value	O
<	O
10−8	O
)	O
and	O
""""	O
structural	O
molecule	O
activity	O
""""	O
(	O
p	O
-	O
value	O
<	O
10−5	O
)	O
,	O
and	O
in	O
biological	O
processes	O
involved	O
with	O
""""	O
neurogenesis	O
""""	O
(	O
p	O
-	O
value	O
<	O
10−38	O
)	O
,	O
""""	O
cell	O
adhesion	O
""""	O
(	O
p	O
-	O
value	O
<	O
10−13	O
)	O
,	O
""""	O
cell	O
motility	O
""""	O
(	O
p	O
-	O
value	O
<	O
10−4	O
)	O
,	O
""""	O
development	O
""""	O
(	O
p	O
-	O
value	O
<	O
10−6	O
)	O
,	O
""""	O
neuropeptide	O
signaling	O
pathway	O
""""	O
(	O
p	O
-	O
value	O
<	O
10−4	O
)	O
,	O
and	O
""""	O
endocytosis	O
""""	O
(	O
p	O
-	O
value	O
<	O
10−4	O
)	O
(	O
Figure	O
2B	O
)	O
.	O

Considering	O
that	O
these	O
were	O
the	O
only	O
categories	O
that	O
were	O
significantly	O
enriched	O
out	O
of	O
more	O
than	O
18,000	O
GO	O
terms	O
,	O
and	O
that	O
randomly	O
selected	O
sets	O
of	O
similar	O
numbers	O
of	O
genes	O
did	O
not	O
reveal	O
statistical	O
differences	O
in	O
GO	O
categories	O
,	O
our	O
results	O
confirmed	O
that	O
the	O
global	O
molecular	O
profiles	O
derived	O
from	O
exon	O
array	O
analysis	O
were	O
consistent	O
with	O
known	O
differences	O
between	O
hESCs	O
and	O
NPs	O
.	O

Figure	O
2Gene	O
Ontology	O
AnalysisDifferential	O
gene	O
expression	O
of	O
hESCs	O
(	O
Cyt	O
-	O
ES	O
and	O
HUES6-ES	O
)	O
and	O
NPs	O
(	O
Cyt	O
-	O
NP	O
,	O
HUES6-NP	O
,	O
and	O
hCNS	O
-	O
SCns	O
)	O
was	O
computed	O
from	O
gene	O
-	O
level	O
signal	O
estimates	O
.	O

Statistical	O
significance	O
for	O
differential	O
gene	O
expression	O
was	O
determined	O
by	O
using	O
t	O
-	O
statistics	O
with	O
Benjamini	O
-	O
Hochberg	O
correction	O
for	O
false	O
discovery	O
rate	O
(	O
p	O
<	O
0.01	O
)	O
.	O

Gene	O
Ontology	O
""""	O
molecular	O
function	O
,	O
""""	O
""""	O
cellular	O
component	O
,	O
""""	O
and	O
""""	O
biological	O
process	O
""""	O
categories	O
,	O
which	O
differed	O
significantly	O
(	O
p	O
<	O
0.05	O
)	O
in	O
the	O
representation	O
between	O
significantly	O
enriched	O
genes	O
(	O
black	O
bars	O
)	O
and	O
all	O
other	O
genes	O
(	O
white	O
bars	O
)	O
,	O
were	O
shown	O
.	O

Statistical	O
significance	O
for	O
GO	O
analysis	O
was	O
assessed	O
by	O
using	O
χ2	O
statistics	O
with	O
Bonferroni	O
correction	O
for	O
multiple	O
hypothesis	O
testing	O
.	O

GO	O
categories	O
are	O
ordered	O
from	O
top	O
to	O
bottom	O
in	O
order	O
of	O
decreasingly	O
significant	O
bias	O
toward	O
enriched	O
genes.	O
(	O
A	O
)	O
GO	O
analysis	O
of	O
enriched	O
genes	O
in	O
hESCs.	O
(	O
B	O
)	O
GO	O
analysis	O
of	O
enriched	O
genes	O
in	O
NPs	O
.	O

To	O
summarize	O
,	O
firstly	O
immunohistochemical	O
and	O
RT	O
-	O
PCR	O
evidence	O
validated	O
that	O
the	O
cells	O
exhibited	O
expected	O
characteristics	O
;	O
secondly	O
,	O
stage	O
-	O
specific	O
marker	O
gene	O
differences	O
by	O
RT	O
-	O
PCR	O
were	O
reflected	O
accurately	O
by	O
gene	O
-	O
level	O
estimates	O
from	O
the	O
exon	O
arrays	O
;	O
thirdly	O
,	O
the	O
hESC	O
-	O
enriched	O
genes	O
were	O
coherent	O
with	O
known	O
genes	O
that	O
controlled	O
pluripotency	O
and	O
self	O
-	O
renewal	O
;	O
and	O
lastly	O
,	O
the	O
global	O
functional	O
profiles	O
exemplified	O
expected	O
biological	O
differences	O
between	O
hESC	O
and	O
NP	O
cells	O
.	O

Description	O
of	O
the	O
Regression	O
-	O
Based	O
Exon	O
Array	O
ProtocolConvinced	O
that	O
the	O
signal	O
estimates	O
from	O
the	O
exon	O
arrays	O
reflected	O
expected	O
molecular	O
and	O
biological	O
differences	O
between	O
hESCs	O
and	O
NPs	O
,	O
we	O
sought	O
to	O
identify	O
AS	O
events	O
.	O

We	O
compared	O
Cyt	O
-	O
ES	O
to	O
hCNS	O
-	O
SCns	O
to	O
illustrate	O
our	O
approach	O
.	O

First	O
we	O
normalized	O
the	O
data	O
and	O
generated	O
signal	O
estimates	O
with	O
Robust	O
Multichip	O
Analysis	O
(	O
RMA	O
)	O
and	O
estimated	O
the	O
probability	O
that	O
each	O
probeset	O
was	O
detected	O
above	O
background	O
(	O
DABG	O
)	O
using	O
publicly	O
available	O
Affymetrix	O
Power	O
Tools	O
(	O
APT	O
)	O
.	O

We	O
analyzed	O
probesets	O
that	O
(	O
i	O
)	O
comprised	O
three	O
or	O
more	O
individual	O
probes	O
;	O
(	O
ii	O
)	O
were	O
localized	O
within	O
the	O
exons	O
of	O
our	O
gene	O
models	O
with	O
evidence	O
from	O
at	O
least	O
three	O
sources	O
(	O
mRNA	O
,	O
EST	O
,	O
or	O
full	O
-	O
length	O
cDNA	O
)	O
;	O
and	O
(	O
iii	O
)	O
were	O
detected	O
above	O
background	O
in	O
at	O
least	O
one	O
of	O
the	O
cell	O
lines	O
.	O

In	O
total	O
,	O
17,430	O
gene	O
models	O
were	O
represented	O
by	O
probesets	O
that	O
satisfied	O
these	O
criteria	O
.	O

Next	O
we	O
asked	O
whether	O
the	O
probeset	O
expression	O
within	O
each	O
gene	O
model	O
was	O
positively	O
correlated	O
for	O
any	O
two	O
cell	O
lines	O
.	O

To	O
do	O
this	O
we	O
calculated	O
the	O
Pearson	O
correlation	O
coefficient	O
between	O
the	O
vectors	O
of	O
median	O
signal	O
estimates	O
across	O
replicates	O
in	O
Cyt	O
-	O
ES	O
versus	O
hCNS	O
-	O
SCns	O
.	O

The	O
vast	O
majority	O
of	O
genes	O
(	O
>	O
80	O
%	O
)	O
was	O
found	O
to	O
have	O
probeset	O
-	O
level	O
Pearson	O
correlation	O
coefficients	O
of	O
greater	O
than	O
0.8	O
(	O
Figure	O
3A	O
)	O
.	O

Next	O
we	O
randomly	O
permuted	O
the	O
association	O
between	O
the	O
median	O
signal	O
estimates	O
and	O
the	O
probesets	O
for	O
each	O
gene	O
in	O
hESCs	O
(	O
or	O
hCNS	O
-	O
SCns	O
)	O
and	O
observed	O
that	O
the	O
distribution	O
of	O
Pearson	O
correlation	O
coefficients	O
for	O
the	O
permuted	O
sets	O
was	O
centered	O
at	O
zero	O
,	O
as	O
expected	O
(	O
Figure	O
3A	O
)	O
.	O

This	O
indicated	O
that	O
the	O
signal	O
estimates	O
for	O
probesets	O
between	O
hESCs	O
and	O
hCNS	O
-	O
SCns	O
were	O
highly	O
correlated	O
and	O
suggested	O
that	O
a	O
scatter	O
plot	O
of	O
probeset	O
signal	O
estimates	O
between	O
hESCs	O
and	O
hCNS	O
-	O
SCns	O
would	O
reveal	O
a	O
linear	O
relationship	O
for	O
the	O
majority	O
of	O
genes	O
.	O

We	O
hypothesized	O
that	O
a	O
linear	O
regression	O
to	O
determine	O
if	O
some	O
probesets	O
behaved	O
unexpectedly	O
in	O
one	O
cell	O
type	O
compared	O
to	O
the	O
other	O
might	O
be	O
a	O
reasonable	O
approach	O
to	O
identify	O
AS	O
exons	O
.	O

Figure	O
3Description	O
of	O
the	O
REAP	O
Algorithm	O
Comparing	O
Exon	O
Array	O
Signal	O
Estimates	O
from	O
hCNS	O
-	O
SCns	O
and	O
Cyt	O
-	O
ES	O
(	O
A	O
)	O
Histogram	O
of	O
Pearson	O
correlation	O
coefficients	O
computed	O
from	O
median	O
signal	O
estimates	O
for	O
probesets	O
between	O
Cyt	O
-	O
ES	O
versus	O
hCNS	O
-	O
SCns	O
for	O
genes	O
(	O
blue	O
bars	O
)	O
.	O

Genes	O
were	O
required	O
to	O
have	O
more	O
than	O
five	O
probesets	O
localized	O
within	O
the	O
exons	O
in	O
the	O
gene	O
.	O

Red	O
bars	O
represented	O
Pearson	O
correlation	O
coefficients	O
computed	O
from	O
exons	O
with	O
shuffled	O
signal	O
estimates.	O
(	O
B	O
)	O

Each	O
probeset	O
contained	O
probeset	O
-	O
level	O
estimates	O
from	O
three	O
replicates	O
each	O
,	O
(	O
a	O
,	O
b	O
,	O
c	O
)	O
in	O
Cyt	O
-	O
ES	O
and	O
(	O
d	O
,	O
e	O
,	O
f	O
)	O
in	O
hCNS	O
-	O
SCns	O
.	O

The	O
five	O
points	O
summarizing	O
the	O
log2	O
probeset	O
-	O
level	O
estimates	O
are	O
indicated	O
by	O
black	O
filled	O
circles.	O
(	O
C	O
)	O

Each	O
probeset	O
was	O
summarized	O
by	O
five	O
points	O
.	O

Scatter	O
plots	O
of	O
signal	O
estimates	O
for	O
probesets	O
that	O
were	O
present	O
in	O
at	O
least	O
one	O
cell	O
type	O
(	O
Cyt	O
-	O
ES	O
or	O
hCNS	O
-	O
SCns	O
)	O
for	O
the	O
EHBP1	B
gene	O
.	O

Probesets	O
were	O
considered	O
present	O
if	O
the	O
DABG	O
p	O
-	O
value	O
was	O
<	O
0.05	O
for	O
all	O
three	O
replicates	O
in	O
the	O
cell	O
type	O
.	O

A	O
regression	O
line	O
derived	O
from	O
robust	O
linear	O
regression	O
with	O
MM	O
estimation	O
is	O
indicated	O
.	O

Points	O
above	O
the	O
line	O
represent	O
probesets	O
within	O
exons	O
that	O
were	O
enriched	O
in	O
Cyt	O
-	O
ES	O
and	O
points	O
below	O
represent	O
exons	O
that	O
were	O
enriched	O
in	O
hCNS	O
-	O
SCns	O
.	O

Points	O
close	O
to	O
the	O
regression	O
line	O
are	O
not	O
significantly	O
different	O
in	O
Cyt	O
-	O
ES	O
versus	O
hCNS	O
-	O
SCns	O
.	O

Boxed	O
points	O
represented	O
the	O
five	O
-	O
point	O
summary	O
of	O
a	O
probeset	O
that	O
was	O
significantly	O
enriched	O
in	O
Cyt	O
-	O
ES	O
but	O
was	O
skipped	O
in	O
hCNS	O
-	O
SCns.	O
(	O
D	O
)	O
Histogram	O
of	O
studentized	O
residuals	O
for	O
points	O
from	O
the	O
scatter	O
plot	O
in	O
(	O
C	O
)	O
in	O
EHBP1.	B
(	O
E	O
)	O
The	O
histogram	O
of	O
studentized	O
residuals	O
for	O
all	O
points	O
for	O
all	O
analyzed	O
probesets	O
(	O
100	O
bins	O
)	O
.	O
(	O
F	O
)	O

The	O
scatter	O
plot	O
of	O
studentized	O
residuals	O
generated	O
from	O
comparing	O
Cyt	O
-	O
ES	O
versus	O
hCNS	O
-	O
SCns	O
and	O
hCNS	O
-	O
SCns	O
versus	O
Cyt	O
-	O
ES	O
of	O
5,000	O
randomly	O
chosen	O
probesets	O
.	O

Here	O
,	O
a	O
possible	O
representation	O
of	O
the	O
data	O
was	O
explored	O
.	O

If	O
we	O
had	O
N	O
replicates	O
in	O
one	O
condition	O
and	O
M	O
replicates	O
in	O
the	O
other	O
,	O
we	O
could	O
consider	O
N*M	O
points	O
if	O
we	O
analyzed	O
every	O
possible	O
pairing	O
.	O

For	O
instance	O
,	O
three	O
replicate	O
signal	O
estimates	O
for	O
every	O
probeset	O
per	O
cell	O
line	O
,	O
such	O
as	O
signal	O
estimates	O
a	O
,	O
b	O
,	O
and	O
c	O
in	O
hESCs	O
and	O
d	O
,	O
e	O
,	O
and	O
f	O
in	O
hCNS	O
-	O
SCns	O
,	O
would	O
translate	O
to	O
pairing	O
every	O
signal	O
(	O
d	O
,	O
a	O
)	O
,	O
(	O
d	O
,	O
b	O
)	O
,	O
(	O
d	O
,	O
c	O
)	O
…	O
(	O
f	O
,	O
a	O
)	O
,	O
(	O
f	O
,	O
b	O
)	O
,	O
(	O
f	O
,	O
c	O
)	O
for	O
linear	O
regression	O
(	O
Figure	O
3B	O
)	O
.	O

Instead	O
,	O
pairing	O
the	O
signal	O
estimates	O
of	O
all	O
replicates	O
in	O
one	O
condition	O
to	O
the	O
median	O
of	O
the	O
other	O
would	O
only	O
require	O
N	O
+	O
M	O
−	O
1	O
points	O
and	O
would	O
capture	O
the	O
variation	O
of	O
the	O
signal	O
estimates	O
of	O
each	O
probeset	O
.	O

For	O
example	O
,	O
we	O
considered	O
(	O
d	O
,	O
b	O
)	O
,	O
(	O
e	O
,	O
a	O
)	O
,	O
(	O
e	O
,	O
b	O
)	O
,	O
(	O
e	O
,	O
c	O
)	O
,	O
and	O
(	O
f	O
,	O
b	O
)	O
points	O
where	O
b	O
and	O
d	O
were	O
the	O
median	O
intensities	O
for	O
the	O
replicates	O
in	O
Cyt	O
-	O
ES	O
and	O
hCNS	O
-	O
SCns	O
,	O
respectively	O
(	O
Figure	O
3B	O
)	O
.	O

A	O
scatter	O
plot	O
of	O
all	O
probesets	O
of	O
the	O
EHBP1	B
(	O
EH	B
domain	I
binding	I
protein	I
,	O
RefSeq	O
identifier	O
NM_015252	O
)	O
is	O
shown	O
in	O
Figure	O
3C	O
in	O
the	O
format	O
described	O
.	O

Each	O
probeset	O
was	O
represented	O
by	O
5	O
points	O
of	O
log	O
-	O
transformed	O
(	O
base	O
2	O
)	O
values	O
;	O
and	O
each	O
point	O
on	O
the	O
scatter	O
plot	O
reflected	O
the	O
extent	O
of	O
inclusion	O
of	O
an	O
exon	O
in	O
hESCs	O
and	O
in	O
hCNS	O
-	O
SCns	O
(	O
Figure	O
3C	O
)	O
.A	O
classical	O
linear	O
regression	O
model	O
could	O
be	O
proposed	O
to	O
fit	O
the	O
response	O
variable	O
yij	O
,	O
the	O
log2	O
expression	O
of	O
probeset	O
i	O
in	O
cell	O
-	O
type	O
j	O
(	O
for	O
example	O
,	O
j	O
is	O
Cyt	O
-	O
ESC	O
)	O
to	O
explanatory	O
variables	O
xik	O
,	O
and	O
the	O
log2	O
expression	O
of	O
probeset	O
i	O
in	O
cell	O
type	O
k	O
(	O
for	O
example	O
,	O
k	O
is	O
hCNS	O
-	O
SCns	O
)	O
.	O

However	O
,	O
classical	O
linear	O
regression	O
by	O
least	O
-	O
squares	O
estimation	O
is	O
biased	O
because	O
the	O
least	O
squares	O
predictions	O
are	O
strongly	O
influenced	O
by	O
the	O
outliers	O
,	O
leading	O
to	O
completely	O
incorrect	O
regression	O
line	O
estimates	O
,	O
masking	O
of	O
the	O
outliers	O
,	O
and	O
incorrect	O
predictions	O
of	O
outliers	O
.	O

Therefore	O
,	O
we	O
applied	O
M	O
-	O
estimation	O
robust	O
regression	O
to	O
estimate	O
the	O
line	O
,	O
which	O
is	O
less	O
sensitive	O
to	O
outliers	O
.	O

Fitting	O
was	O
performed	O
using	O
an	O
iterated	O
,	O
re	O
-	O
weighted	O
least	O
squares	O
analysis	O
.	O

Our	O
assumption	O
was	O
that	O
most	O
of	O
the	O
points	O
were	O
""""	O
correct	O
,	O
""""	O
i.e.	O
,	O
that	O
most	O
of	O
the	O
exons	O
were	O
constitutively	O
spliced	O
.	O

Thus	O
,	O
robust	O
regression	O
would	O
find	O
the	O
line	O
that	O
was	O
least	O
dependent	O
on	O
outliers	O
,	O
which	O
would	O
be	O
potential	O
AS	O
exons	O
.	O

This	O
assumption	O
was	O
substantiated	O
by	O
our	O
observation	O
that	O
,	O
using	O
publicly	O
available	O
ESTs	O
and	O
mRNAs	O
,	O
a	O
minority	O
of	O
human	O
exons	O
(	O
7	O
%	O
)	O
have	O
evidence	O
for	O
exon	O
-	O
skipping	O
,	O
the	O
most	O
common	O
form	O
of	O
AS	O
.	O

Using	O
robust	O
regression	O
,	O
the	O
regression	O
line	O
for	O
Cyt	O
-	O
ESC	O
versus	O
hCNS	O
-	O
SCns	O
in	O
the	O
EHBP1	B
gene	O
is	O
illustrated	O
in	O
Figure	O
3C	O
.	O

The	O
boxed	O
points	O
belonged	O
to	O
a	O
probeset	O
that	O
was	O
enriched	O
in	O
hESCs	O
but	O
depleted	O
in	O
hCNS	O
-	O
SCns	O
,	O
which	O
was	O
suspected	O
to	O
be	O
due	O
to	O
AS	O
.	O

The	O
difference	O
between	O
the	O
actual	O
and	O
regression	O
-	O
based	O
predicted	O
value	O
,	O
normalized	O
by	O
the	O
estimate	O
of	O
its	O
standard	O
deviation	O
,	O
is	O
called	O
the	O
studentized	O
residuals	O
.	O

Studentized	O
residuals	O
were	O
computed	O
for	O
all	O
probeset	O
pairs	O
in	O
EHBP1	B
,	O
and	O
the	O
histogram	O
depicting	O
their	O
distribution	O
is	O
illustrated	O
in	O
Figure	O
3D	O
.	O

As	O
expected	O
,	O
the	O
mean	O
of	O
the	O
distribution	O
was	O
close	O
to	O
zero	O
,	O
and	O
the	O
distribution	O
was	O
approximated	O
by	O
a	O
t	O
-	O
distribution	O
with	O
n	O
-	O
p-1	O
degrees	O
of	O
freedom	O
,	O
where	O
n	O
was	O
the	O
number	O
of	O
points	O
on	O
the	O
scatter	O
plot	O
,	O
and	O
the	O
number	O
of	O
parameters	O
p	O
was	O
2	O
.	O

The	O
boxed	O
points	O
had	O
studentized	O
residuals	O
of	O
1.829	O
,	O
3.104	O
,	O
2.634	O
,	O
3.012	O
,	O
and	O
2.125	O
with	O
p	O
-	O
values	O
of	O
0.034	O
,	O
0.00119	O
,	O
0.00477	O
,	O
0.00158	O
,	O
and	O
0.01780	O
,	O
respectively	O
,	O
computed	O
based	O
on	O
the	O
t	O
-	O
distribution	O
(	O
Figure	O
3C	O
)	O
.	O

At	O
a	O
stringent	O
p	O
-	O
value	O
cutoff	O
of	O
0.01	O
,	O
four	O
of	O
the	O
five	O
studentized	O
residuals	O
were	O
designated	O
as	O
significant	O
""""	O
outliers	O
,	O
""""	O
indicating	O
that	O
the	O
probeset	O
was	O
""""	O
unusual	O
.	O
""""	O
RT	O
-	O
PCR	O
confirmed	O
that	O
the	O
exon	O
,	O
represented	O
by	O
the	O
probeset	O
,	O
was	O
indeed	O
differentially	O
included	O
in	O
hESCs	O
and	O
skipped	O
in	O
hCNS	O
-	O
SCns	O
(	O
Figure	O
7B	O
)	O
.	O

Applying	O
this	O
approach	O
to	O
all	O
gene	O
models	O
revealed	O
that	O
,	O
as	O
expected	O
,	O
the	O
majority	O
of	O
studentized	O
residuals	O
are	O
centered	O
at	O
zero	O
(	O
Figure	O
3E	O
)	O
.	O

Thus	O
far	O
in	O
the	O
example	O
,	O
our	O
analysis	O
was	O
based	O
on	O
regression	O
of	O
hESCs	O
(	O
y	O
-	O
axis	O
)	O
versus	O
hCNS	O
-	O
SCns	O
(	O
x	O
-	O
axis	O
)	O
(	O
Figure	O
3B–3D	O
)	O
.	O

However	O
,	O
robust	O
regression	O
as	O
described	O
was	O
not	O
symmetrical	O
,	O
i.e.	O
,	O
parameter	O
estimation	O
of	O
y	O
as	O
a	O
function	O
of	O
x	O
was	O
not	O
the	O
same	O
as	O
that	O
of	O
x	O
as	O
a	O
function	O
of	O
y.	O
The	O
negative	O
slope	O
revealed	O
that	O
probesets	O
enriched	O
in	O
hESCs	O
versus	O
hCNS	O
-	O
SCns	O
(	O
positive	O
valued	O
)	O
,	O
were	O
expectedly	O
depleted	O
when	O
hCNS	O
-	O
SCns	O
was	O
compared	O
to	O
hESCs	O
(	O
negative	O
valued	O
;	O
Figure	O
3F	O
)	O
.	O

As	O
our	O
method	O
for	O
predicting	O
candidate	O
alternative	O
exons	O
was	O
based	O
on	O
identification	O
of	O
outliers	O
using	O
robust	O
regression	O
,	O
we	O
named	O
the	O
method	O
REAP	O
.	O

Identification	O
and	O
Removal	O
of	O
False	O
PositivesIn	O
the	O
process	O
of	O
experimentally	O
validating	O
our	O
predictions	O
,	O
we	O
encountered	O
three	O
main	O
sources	O
of	O
false	O
positives	O
(	O
FP	O
)	O
from	O
robust	O
regression	O
.	O

First	O
,	O
we	O
identified	O
genes	O
with	O
probeset	O
signal	O
estimates	O
that	O
were	O
poorly	O
correlated	O
and	O
were	O
not	O
amenable	O
to	O
our	O
method	O
.	O

As	O
an	O
example	O
,	O
the	O
median	O
probeset	O
signal	O
estimates	O
in	O
hESCs	O
and	O
hCNS	O
-	O
SCns	O
of	O
the	O
FIP1L1	B
gene	O
(	O
gene	O
identifiers	O
BC011543	O
,	O
AL136910	O
)	O
had	O
a	O
Pearson	O
correlation	O
coefficient	O
of	O
0.38	O
,	O
and	O
the	O
distribution	O
of	O
points	O
was	O
not	O
amenable	O
to	O
robust	O
regression	O
(	O
Figure	O
4A	O
)	O
.	O

To	O
avoid	O
inappropriate	O
application	O
of	O
REAP	O
and	O
generating	O
false	O
predictions	O
,	O
we	O
empirically	O
determined	O
that	O
a	O
gene	O
had	O
to	O
have	O
a	O
Pearson	O
correlation	O
coefficient	O
cutoff	O
of	O
0.6	O
before	O
being	O
amenable	O
to	O
REAP	O
analysis	O
.	O

Next	O
,	O
we	O
managed	O
two	O
additional	O
sources	O
of	O
FPs	O
,	O
namely	O
""""	O
high	O
-	O
leverage	O
""""	O
and	O
""""	O
high	O
-	O
influence	O
""""	O
points	O
,	O
which	O
we	O
were	O
able	O
to	O
identify	O
by	O
computing	O
the	O
following	O
metrics	O
.	O

For	O
every	O
point	O
,	O
we	O
computed	O
(	O
i	O
)	O
the	O
studentized	O
residual	O
(	O
as	O
described	O
above	O
)	O
,	O
(	O
ii	O
)	O
the	O
influence	O
,	O
and	O
(	O
iii	O
)	O
the	O
leverage	O
(	O
see	O
Materials	O
and	O
Methods	O
for	O
more	O
details	O
)	O
.	O

Leverage	O
assessed	O
how	O
far	O
away	O
a	O
value	O
of	O
the	O
independent	O
variable	O
was	O
from	O
the	O
mean	O
value	O
;	O
the	O
farther	O
away	O
the	O
observation	O
the	O
more	O
leverage	O
it	O
had	O
.	O

The	O
influence	O
of	O
a	O
point	O
was	O
related	O
to	O
its	O
covariance	O
ratio	O
:	O
a	O
covariance	O
ratio	O
larger	O
(	O
or	O
smaller	O
)	O
than	O
1	O
implied	O
that	O
the	O
point	O
was	O
closer	O
(	O
or	O
farther	O
)	O
than	O
was	O
typical	O
to	O
the	O
regression	O
line	O
,	O
so	O
removing	O
it	O
would	O
hurt	O
(	O
or	O
help	O
)	O
the	O
accuracy	O
of	O
the	O
line	O
and	O
would	O
increase	O
(	O
or	O
decrease	O
)	O
the	O
error	O
term	O
variance	O
.	O

Influence	O
was	O
computed	O
as	O
the	O
absolute	O
difference	O
between	O
the	O
covariance	O
ratio	O
and	O
unity	O
.	O

To	O
illustrate	O
further	O
,	O
a	O
point	O
was	O
classified	O
as	O
an	O
""""	O
outlier	O
""""	O
if	O
it	O
had	O
a	O
large	O
studentized	O
residual	O
(	O
p	O
<	O
0.01	O
)	O
and	O
low	O
leverage	O
(	O
boxed	O
point	O
""""	O
a	O
""""	O
)	O
;	O
as	O
a	O
""""	O
high	O
-	O
leverage	O
""""	O
point	O
if	O
it	O
had	O
a	O
low	O
studentized	O
residual	O
and	O
high	O
leverage	O
(	O
boxed	O
point	O
""""	O
b	O
""""	O
)	O
;	O
and	O
as	O
a	O
""""	O
high	O
-	O
influence	O
""""	O
point	O
if	O
it	O
had	O
a	O
high	O
studentized	O
residual	O
,	O
high	O
leverage	O
,	O
and	O
high	O
influence	O
(	O
boxed	O
point	O
""""	O
c	O
""""	O
;	O
Figure	O
4B	O
)	O
.	O

Points	O
that	O
resembled	O
boxed	O
point	O
""""	O
a	O
""""	O
were	O
designated	O
as	O
potential	O
AS	O
events	O
.	O

For	O
example	O
,	O
four	O
of	O
the	O
five	O
boxed	O
points	O
in	O
Figure	O
3C	O
were	O
""""	O
outliers	O
,	O
""""	O
and	O
RT	O
-	O
PCR	O
validation	O
indicated	O
that	O
the	O
exon	O
represented	O
by	O
the	O
probeset	O
was	O
indeed	O
skipped	O
in	O
hCNS	O
-	O
SCns	O
(	O
EHBP1	O
,	O
Figure	O
7B	O
)	O
.	O

Points	O
that	O
were	O
""""	O
high	O
-	O
leverage	O
,	O
""""	O
such	O
as	O
the	O
five	O
points	O
in	O
the	O
CLCN2	B
gene	O
,	O
were	O
experimentally	O
verified	O
to	O
be	O
a	O
FP	O
(	O
Figure	O
4C	O
;	O
unpublished	O
data	O
)	O
.	O

Points	O
that	O
were	O
""""	O
high	O
-	O
influence	O
,	O
""""	O
such	O
as	O
the	O
four	O
of	O
five	O
boxed	O
points	O
in	O
the	O
ABCA3	B
gene	O
were	O
also	O
experimentally	O
verified	O
to	O
be	O
a	O
FP	O
(	O
Figure	O
4D	O
;	O
unpublished	O
data	O
)	O
.	O

In	O
conclusion	O
,	O
in	O
order	O
to	O
reduce	O
the	O
FP	O
rate	O
,	O
all	O
points	O
were	O
evaluated	O
according	O
to	O
the	O
metrics	O
described	O
,	O
and	O
points	O
that	O
were	O
significant	O
""""	O
outliers	O
""""	O
were	O
considered	O
putative	O
AS	O
events	O
.	O

Figure	O
4Sources	O
of	O
False	O
Positives	O
(	O
A	O
)	O
Scatter	O
plot	O
of	O
points	O
for	O
the	O
FIP1L1	B
gene	O
and	O
the	O
line	O
representing	O
the	O
robust	O
regression	O
estimate.	O
(	O
B	O
)	O

Boxed	O
point	O
""""	O
a	O
""""	O
represents	O
a	O
significant	O
""""	O
outlier	O
""""	O
(	O
with	O
a	O
significantly	O
different	O
studentized	O
residual	O
and	O
low	O
leverage	O
)	O
.	O

Boxed	O
point	O
""""	O
b	O
""""	O
represents	O
a	O
""""	O
high	O
leverage	O
""""	O
point	O
(	O
low	O
studentized	O
residual	O
and	O
a	O
high	O
leverage	O
)	O
.	O

Boxed	O
point	O
""""	O
c	O
""""	O
represents	O
a	O
""""	O
high	O
influence	O
""""	O
point	O
(	O
high	O
studentized	O
residual	O
,	O
high	O
leverage	O
,	O
and	O
high	O
influence	O
)	O
.	O
(	O
C	O
)	O
Scatter	O
plot	O
of	O
points	O
for	O
the	O
CLCN2	B
gene	O
.	O

Boxed	O
points	O
represent	O
""""	O
high	O
leverage	O
""""	O
points.	O
(	O
D	O
)	O
Scatter	O
plot	O
of	O
points	O
for	O
the	O
ABCA3	B
gene	O
.	O

Boxed	O
points	O
represent	O
""""	O
high	O
influence	O
""""	O
points	O
.	O

Global	O
Identification	O
and	O
Characterization	O
of	O
REAP	O
[	O
+	O
]	O
ExonsREAP	O
was	O
applied	O
to	O
identify	O
AS	O
events	O
in	O
NPs	O
compared	O
to	O
hESCs	O
:	O
Cyt	O
-	O
NP	O
versus	O
Cyt	O
-	O
ES	O
;	O
HUES6-NP	O
versus	O
HUES6-ES	O
;	O
hCNS	O
-	O
SCns	O
versus	O
Cyt	O
-	O
ES	O
,	O
and	O
hCNS	O
-	O
SCns	O
versus	O
HUES6-ES	O
.	O

After	O
removing	O
potential	O
FPs	O
,	O
11,348	O
genes	O
containing	O
158,657	O
probesets	O
were	O
scored	O
by	O
REAP.As	O
described	O
above	O
,	O
for	O
each	O
pair	O
of	O
cell	O
lines	O
compared	O
,	O
each	O
probset	O
was	O
represented	O
by	O
five	O
points	O
,	O
where	O
each	O
point	O
was	O
defined	O
a	O
significant	O
outlier	O
if	O
it	O
had	O
a	O
high	O
residual	O
(	O
p	O
<	O
0.01	O
)	O
,	O
low	O
influence	O
,	O
and	O
high	O
leverage	O
.	O

Points	O
per	O
probeset	O
should	O
be	O
correlated	O
;	O
in	O
other	O
words	O
,	O
if	O
one	O
point	O
was	O
a	O
significant	O
outlier	O
,	O
the	O
other	O
points	O
were	O
expected	O
to	O
be	O
outliers	O
as	O
well	O
.	O

To	O
ensure	O
that	O
this	O
was	O
the	O
case	O
,	O
we	O
counted	O
the	O
number	O
of	O
probesets	O
with	O
N	O
significant	O
outliers	O
,	O
where	O
N	O
was	O
varied	O
from	O
0	O
to	O
5	O
.	O

Next	O
,	O
the	O
identity	O
of	O
the	O
probesets	O
and	O
points	O
derived	O
from	O
them	O
were	O
exchanged	O
with	O
other	O
probesets	O
,	O
keeping	O
constant	O
the	O
total	O
number	O
of	O
points	O
that	O
were	O
considered	O
significant	O
outliers	O
.	O

At	O
N	O
=	O
0	O
,	O
we	O
observed	O
approximately	O
equal	O
numbers	O
of	O
probesets	O
in	O
the	O
actual	O
versus	O
shuffled	O
controls	O
.	O

In	O
contrast	O
,	O
we	O
observed	O
that	O
there	O
were	O
1.5	O
times	O
more	O
probesets	O
with	O
N	O
=	O
2	O
significant	O
outliers	O
relative	O
to	O
shuffled	O
controls	O
;	O
12–31	O
times	O
more	O
probesets	O
with	O
N	O
=	O
3	O
;	O
and	O
17–612	O
times	O
more	O
probesets	O
that	O
had	O
N	O
=	O
4	O
significant	O
outliers	O
(	O
Figure	O
5A	O
;	O
see	O
Table	O
S1	O
)	O
.	O

For	O
example	O
,	O
in	O
hCNS	O
-	O
SCns	O
compared	O
to	O
Cyt	O
-	O
ES	O
,	O
approximately	O
0.39	O
%	O
(	O
490	O
of	O
124,604	O
)	O
of	O
probesets	O
had	O
three	O
significant	O
outliers	O
and	O
0.25	O
%	O
(	O
308	O
probesets	O
)	O
had	O
four	O
significant	O
outliers	O
,	O
relative	O
to	O
0.02	O
%	O
and	O
0	O
%	O
of	O
shuffled	O
controls	O
,	O
respectively	O
.	O

Figure	O
5Correlation	O
between	O
""""	O
"Outliers"""	O
(	O
A	O
)	O
The	O
number	O
of	O
probesets	O
with	O
N	O
significant	O
""""	O
outliers	O
""""	O
was	O
determined	O
for	O
hCNS	O
-	O
SCns	O
versus	O
Cyt	O
-	O
ES	O
,	O
hCNS	O
-	O
SCns	O
versus	O
HUES6-ES	O
,	O
Cyt	O
-	O
NPs	O
versus	O
Cyt	O
-	O
ES	O
,	O
and	O
HUES6-NPs	O
versus	O
HUES6-ES	O
(	O
N	O
=	O
0	O
,	O
1	O
,	O
2	O
,	O
3	O
,	O
4	O
,	O
5	O
)	O
.	O

For	O
comparison	O
,	O
points	O
to	O
probeset	O
relationships	O
were	O
randomly	O
permuted	O
,	O
retaining	O
the	O
same	O
number	O
of	O
""""	O
outliers	O
.	O
""""	O

Vertical	O
bars	O
represent	O
the	O
ratio	O
between	O
the	O
number	O
of	O
actual	O
points	O
and	O
the	O
randomly	O
permutated	O
sets.	O
(	O
B	O
)	O
Similar	O
to	O
(	O
A	O
)	O
,	O
except	O
points	O
were	O
counted	O
as	O
""""	O
outliers	O
""""	O
only	O
if	O
they	O
were	O
""""	O
outliers	O
""""	O
in	O
both	O
hCNS	O
-	O
SCns	O
versus	O
Cyt	O
-	O
ES	O
and	O
hCNS	O
-	O
SCns	O
versus	O
HUES6-ES	O
(	O
combined	O
hCNS	O
-	O
SCns	O
versus	O
hESC	O
;	O
blue	O
bars	O
)	O
;	O
in	O
both	O
HUES6-NP	O
versus	O
HUES6-ES	O
and	O
Cyt	O
-	O
NP	O
versus	O
Cyt	O
-	O
ES	O
(	O
combined	O
derived	O
NP	O
versus	O
hESC	O
;	O
red	O
bars	O
)	O
;	O
and	O
in	O
all	O
four	O
comparisons	O
(	O
combined	O
NP	O
versus	O
hESC	O
;	O
yellow	O
bar	O
)	O
.Next	O
we	O
asked	O
whether	O
the	O
overlap	O
between	O
related	O
comparisons	O
was	O
higher	O
than	O
expected	O
.	O

Comparing	O
the	O
significant	O
probesets	O
between	O
hCNS	O
-	O
SCns	O
versus	O
Cyt	O
-	O
ES	O
and	O
hCNS	O
-	O
SCns	O
versus	O
HUES6-ES	O
revealed	O
672	O
significant	O
probesets	O
(	O
N	O
≥	O
2	O
)	O
,	O
whereas	O
if	O
we	O
shuffled	O
the	O
associations	O
between	O
probeset	O
identity	O
and	O
significant	O
outliers	O
,	O
only	O
four	O
significant	O
probesets	O
(	O
N	O
≥	O
2	O
)	O
were	O
identified	O
—	O
a	O
168-fold	O
enrichment	O
(	O
Figure	O
5B	O
,	O
Table	O
S1	O
)	O
.	O

A	O
total	O
of	O
236	O
significant	O
probesets	O
overlapped	O
when	O
we	O
compared	O
the	O
derived	O
NPs	O
to	O
hESCs	O
(	O
Cyt	O
-	O
NP	O
versus	O
Cyt	O
-	O
ES	O
and	O
HUES6-NP	O
versus	O
HUES6-ES	O
)	O
,	O
relative	O
to	O
seven	O
significant	O
probesets	O
(	O
34-fold	O
enrichment	O
)	O
.At	O
a	O
cutoff	O
of	O
two	O
significant	O
outliers	O
,	O
1,737	O
probesets	O
contained	O
in	O
internal	O
exons	O
were	O
defined	O
as	O
positive	O
REAP	O
predictions	O
(	O
hereafter	O
called	O
REAP	O
[	O
+	O
]	O
)	O
exons	O
—	O
candidate	O
AS	O
events	O
that	O
distinguished	O
NP	O
from	O
hESC	O
.	O

Surprisingly	O
,	O
we	O
observed	O
that	O
the	O
majority	O
of	O
REAP	O
[	O
+	O
]	O
exons	O
were	O
specific	O
to	O
the	O
pair	O
of	O
hESC	O
and	O
NP	O
that	O
was	O
compared	O
,	O
likely	O
reflecting	O
differences	O
in	O
genetic	O
origins	O
and/or	O
culturing	O
and	O
differentiation	O
conditions	O
of	O
the	O
cell	O
lines	O
:	O
614	O
REAP	O
[	O
+	O
]	O
events	O
were	O
unique	O
to	O
hCNS	O
-	O
SCns	O
versus	O
HUE6-ES	O
;	O
220	O
were	O
unique	O
to	O
hCNS	O
-	O
SCns	O
versus	O
Cyt	O
-	O
ES	O
;	O
439	O
were	O
unique	O
to	O
HUES6-NP	O
versus	O
HUES6-ES	O
;	O
and	O
250	O
were	O
unique	O
to	O
Cyt	O
-	O
NP	O
versus	O
Cyt	O
-	O
ES	O
.	O

The	O
shared	O
events	O
between	O
pairs	O
of	O
comparisons	O
made	O
up	O
a	O
minority	O
of	O
the	O
total	O
number	O
identified	O
:	O
102	O
REAP	O
[	O
+	O
]	O
events	O
were	O
found	O
to	O
be	O
in	O
common	O
between	O
hCNS	O
-	O
SCns	O
versus	O
Cyt	O
-	O
ES	O
and	O
hCNS	O
-	O
SCns	O
versus	O
HUES6-ES	O
;	O
48	O
between	O
hCNS	O
-	O
SCns	O
versus	O
HUES6-ES	O
and	O
HUES6-NP	O
versus	O
HUES6-ES	O
;	O
and	O
only	O
17	O
between	O
hCNS	O
-	O
SCns	O
versus	O
Cyt	O
-	O
ES	O
and	O
Cyt	O
-	O
NP	O
versus	O
Cyt	O
-	O
ES	O
(	O
Table	O
S2	O
)	O
.	O

Comparison	O
of	O
REAP	O
to	O
EST	O
-	O
Based	O
Method	O
and	O
ACEScanTraditionally	O
,	O
AS	O
exons	O
were	O
discovered	O
by	O
using	O
EST	O
alignments	O
to	O
genomic	O
loci	O
,	O
and	O
also	O
more	O
recently	O
by	O
computational	O
algorithms	O
that	O
used	O
sequence	O
information	O
extracted	O
from	O
multiple	O
genomes	O
.	O

Here	O
,	O
we	O
compared	O
REAP	O
predictions	O
to	O
both	O
approaches	O
.	O

In	O
the	O
first	O
comparison	O
,	O
publicly	O
available	O
ESTs	O
and	O
mRNA	O
transcripts	O
were	O
aligned	O
to	O
the	O
human	O
genome	O
sequence	O
.	O

13,934	O
exons	O
with	O
evidence	O
for	O
exon	O
-	O
skipping	O
and/or	O
inclusion	O
(	O
EST	O
-	O
SE	O
for	O
EST	O
-	O
verified	O
skipped	O
exons	O
)	O
were	O
generated	O
,	O
comprising	O
∼7	O
%	O
of	O
all	O
internal	O
exons	O
.	O

First	O
we	O
analyzed	O
Cyt	O
-	O
ES	O
versus	O
hCNS	O
-	O
SCns	O
.	O

If	O
we	O
required	O
that	O
none	O
of	O
the	O
points	O
per	O
probeset	O
(	O
exon	O
)	O
was	O
significant	O
,	O
6	O
%	O
(	O
4,402	O
of	O
71,731	O
)	O
of	O
exons	O
(	O
after	O
probeset	O
mapping	O
)	O
had	O
evidence	O
for	O
EST	O
-	O
SE	O
(	O
Figure	O
6A	O
)	O
.	O

Shuffling	O
the	O
mapping	O
between	O
these	O
probesets	O
and	O
exons	O
resulted	O
in	O
8	O
%	O
(	O
5,777	O
of	O
71,731	O
)	O
of	O
exons	O
with	O
evidence	O
for	O
EST	O
-	O
SE	O
(	O
Figure	O
6A	O
)	O
.	O

These	O
percentages	O
were	O
not	O
significantly	O
different	O
from	O
the	O
7	O
%	O
of	O
exons	O
with	O
EST	O
evidence	O
for	O
AS	O
observed	O
from	O
using	O
all	O
exons	O
.	O

By	O
raising	O
the	O
requirement	O
that	O
probesets	O
had	O
to	O
contain	O
at	O
least	O
one	O
significant	O
point	O
to	O
five	O
significant	O
points	O
,	O
the	O
percentage	O
of	O
EST	O
-	O
SE	O
increased	O
dramatically	O
from	O
11	O
%	O
(	O
531	O
of	O
4,898	O
exons	O
)	O
to	O
26	O
%	O
(	O
33	O
of	O
126	O
)	O
.	O

In	O
comparison	O
,	O
the	O
shuffled	O
probesets	O
at	O
the	O
same	O
requirements	O
remained	O
at	O
∼8	O
%	O
,	O
rising	O
slightly	O
to	O
11	O
%	O
at	O
five	O
points	O
,	O
due	O
to	O
small	O
sample	O
sizes	O
.	O

Similar	O
trends	O
were	O
observed	O
with	O
hCNS	O
-	O
SCns	O
versus	O
HUES6-ES	O
and	O
the	O
derived	O
NPs	O
versus	O
hESCs	O
(	O
Figure	O
6A	O
)	O
.	O

Therefore	O
,	O
we	O
concluded	O
that	O
REAP	O
[	O
+	O
]	O
exons	O
were	O
enriched	O
for	O
AS	O
events	O
independently	O
identified	O
by	O
a	O
transcript	O
-	O
based	O
approach	O
.	O

Figure	O
6Comparison	O
of	O
REAP	O
Predictions	O
for	O
hCNS	O
-	O
SCns	O
versus	O
Cyt	O
-	O
hES	O
,	O
hCNS	O
-	O
SCns	O
versus	O
HUES6-ES	O
,	O
Cyt	O
-	O
NP	O
versus	O
Cyt	O
-	O
ES	O
,	O
and	O
HUES6-NPs	O
versus	O
HUES6-ES	O
with	O
Alternative	O
Exons	O
Identified	O
by	O
an	O
EST	O
-	O
Based	O
Method	O
and	O
ACEScan	O
(	O
A	O
)	O
Black	O
-	O
filled	O
squares	O
represented	O
the	O
fraction	O
of	O
exons	O
containing	O
probesets	O
with	O
N	O
significant	O
points	O
that	O
had	O
EST	O
evidence	O
for	O
exon	O
inclusion	O
or	O
exclusion	O
(	O
N	O
=	O
0	O
,	O
1	O
,	O
2	O
,	O
3	O
,	O
4	O
and	O
5	O
)	O
.	O

White	O
-	O
filled	O
triangles	O
represented	O
similarly	O
computed	O
fractions	O
with	O
permuted	O
probeset	O
to	O
exon	O
mappings.	O
(	O
B	O
)	O
Black	O
-	O
filled	O
squares	O
represented	O
the	O
fraction	O
of	O
exons	O
containing	O
probesets	O
with	O
N	O
significant	O
points	O
that	O
had	O
ACEScan	O
positive	O
scores	O
,	O
indicative	O
of	O
evolutionarily	O
conserved	O
alternative	O
exons	O
.	O

White	O
-	O
filled	O
triangles	O
represented	O
similarly	O
computed	O
fractions	O
with	O
permuted	O
probeset	O
to	O
exon	O
mappings	O
.	O

Next	O
,	O
we	O
compared	O
REAP	O
predictions	O
to	O
a	O
computational	O
approach	O
of	O
identifying	O
exons	O
with	O
AS	O
conserved	O
in	O
human	O
and	O
mouse	O
,	O
ACEScan	O
[	O
55	O
]	O
.	O

ACEScan	O
receives	O
as	O
input	O
orthologous	O
human	O
–	O
mouse	O
exon	O
pairs	O
and	O
flanking	O
intronic	O
regions	O
and	O
computes	O
sequence	O
features	O
and	O
integrates	O
the	O
features	O
into	O
a	O
machine	O
-	O
learning	O
algorithm	O
to	O
assign	O
a	O
real	O
-	O
valued	O
score	O
to	O
the	O
exon	O
.	O

A	O
positive	O
score	O
indicated	O
a	O
higher	O
likelihood	O
of	O
being	O
AS	O
in	O
both	O
human	O
and	O
mouse	O
.	O

ACEScan	O
was	O
updated	O
in	O
the	O
following	O
ways	O
.	O

Firstly	O
,	O
instead	O
of	O
relying	O
on	O
orthology	O
information	O
by	O
Ensembl	O
,	O
and	O
then	O
aligning	O
flanking	O
introns	O
in	O
""""	O
orthologous	O
""""	O
exons	O
,	O
conserved	O
exonic	O
and	O
intronic	O
regions	O
in	O
human	O
and	O
mouse	O
from	O
genome	O
-	O
wide	O
multiple	O
alignments	O
were	O
extracted	O
.	O

Secondly	O
,	O
whereas	O
in	O
our	O
previous	O
analysis	O
exons	O
from	O
the	O
longest	O
transcript	O
in	O
Ensembl	O
were	O
utilized	O
,	O
now	O
we	O
collapsed	O
all	O
the	O
transcripts	O
available	O
at	O
the	O
UCSC	O
genome	O
browser	O
and	O
analyzed	O
all	O
exons	O
in	O
the	O
entire	O
gene	O
loci	O
.	O

ACEScan	O
was	O
utilized	O
to	O
assign	O
ACEScan	O
scores	O
to	O
all	O
∼162,000	O
internal	O
exons	O
in	O
our	O
genes	O
.	O

Exons	O
annotated	O
as	O
first	O
or	O
last	O
exons	O
in	O
Refseq	O
mRNAs	O
were	O
excluded	O
from	O
our	O
analysis	O
,	O
resulting	O
in	O
4,487	O
positive	O
-	O
scoring	O
exons	O
,	O
2-fold	O
more	O
exons	O
than	O
originally	O
published	O
.	O

Here	O
we	O
repeated	O
our	O
analysis	O
with	O
exons	O
with	O
positive	O
ACEScan	O
scores	O
(	O
ACE	O
[	O
+	O
]	O
)	O
instead	O
of	O
EST	O
-	O
SEs	O
.	O

If	O
we	O
required	O
that	O
none	O
of	O
the	O
points	O
per	O
probeset	O
(	O
exon	O
)	O
was	O
significant	O
,	O
2	O
%	O
(	O
1,645	O
of	O
71,731	O
)	O
of	O
exons	O
(	O
after	O
probeset	O
mapping	O
)	O
were	O
ACE	O
[	O
+	O
]	O
(	O
Figure	O
6B	O
)	O
.	O

Shuffling	O
the	O
mapping	O
between	O
these	O
probesets	O
and	O
exons	O
resulted	O
in	O
3	O
%	O
(	O
2,044	O
of	O
71,731	O
)	O
of	O
exons	O
being	O
ACE	O
[	O
+	O
]	O
(	O
Figure	O
6B	O
)	O
.	O

These	O
percentages	O
were	O
not	O
significantly	O
different	O
from	O
the	O
2.7	O
%	O
observed	O
from	O
all	O
exons	O
(	O
4,487	O
of	O
the	O
162,000	O
exons	O
that	O
were	O
scored	O
by	O
ACEScan	O
)	O
.	O

By	O
raising	O
the	O
requirement	O
that	O
probesets	O
had	O
to	O
contain	O
five	O
significant	O
points	O
,	O
the	O
percentage	O
of	O
ACE	O
[	O
+	O
]	O
exons	O
increased	O
from	O
4	O
%	O
to	O
11	O
%	O
.	O

However	O
,	O
the	O
sample	O
sizes	O
were	O
small	O
.	O

In	O
comparison	O
,	O
the	O
shuffled	O
probesets	O
at	O
the	O
same	O
requirements	O
remained	O
at	O
∼4	O
%	O
.	O

Similar	O
overall	O
trends	O
were	O
observed	O
with	O
hCNS	O
-	O
SCns	O
versus	O
HUES6-ES	O
and	O
the	O
derived	O
NPs	O
versus	O
hESCs	O
(	O
Figure	O
6B	O
)	O
.	O

In	O
total	O
,	O
7.5	O
%	O
(	O
131	O
of	O
1,737	O
)	O
of	O
REAP	O
[	O
+	O
]	O
exons	O
were	O
designated	O
as	O
ACEScan	O
[	O
+	O
]	O
compared	O
to	O
2.4	O
%	O
(	O
2,328	O
of	O
97,437	O
)	O
of	O
REAP	O
[	O
−	O
]	O
exons	O
.	O

This	O
result	O
suggested	O
that	O
a	O
small	O
but	O
significantly	O
enriched	O
fraction	O
of	O
AS	O
events	O
in	O
hESCs	O
versus	O
NPs	O
was	O
likely	O
to	O
be	O
evolutionarily	O
conserved	O
in	O
human	O
and	O
mouse	O
.	O

In	O
conclusion	O
,	O
our	O
results	O
suggested	O
that	O
REAP	O
predictions	O
were	O
congruent	O
with	O
predictions	O
from	O
two	O
independent	O
,	O
orthogonal	O
methods	O
.	O

Experimental	O
Validation	O
of	O
Alternative	O
ExonsThe	O
sensitivity	O
and	O
specificity	O
of	O
REAP	O
in	O
the	O
identification	O
of	O
REAP	O
[	O
+	O
]	O
exons	O
was	O
tested	O
by	O
RT	O
-	O
PCR	O
.	O

To	O
validate	O
REAP	O
[	O
+	O
]	O
alternative	O
exons	O
,	O
RT	O
-	O
PCR	O
primers	O
were	O
designed	O
in	O
the	O
flanking	O
exons	O
to	O
amplify	O
both	O
isoforms	O
.	O

To	O
be	O
a	O
positively	O
validated	O
candidate	O
,	O
the	O
PCR	O
products	O
on	O
a	O
gel	O
had	O
to	O
satisfy	O
all	O
of	O
the	O
following	O
criteria	O
:	O
(	O
i	O
)	O
at	O
least	O
one	O
isoform	O
with	O
the	O
expected	O
size	O
must	O
be	O
visible	O
in	O
each	O
cell	O
type	O
;	O
(	O
ii	O
)	O
the	O
relative	O
abundance	O
of	O
the	O
two	O
isoforms	O
must	O
be	O
altered	O
between	O
two	O
cell	O
types	O
and	O
the	O
direction	O
of	O
change	O
have	O
to	O
be	O
consistent	O
with	O
the	O
REAP	O
studentized	O
residuals	O
:	O
in	O
our	O
study	O
positive	O
residuals	O
implied	O
inclusion	O
in	O
hESCs	O
and	O
skipping	O
in	O
NPs	O
,	O
and	O
negative	O
residuals	O
implied	O
inclusion	O
in	O
NP	O
and	O
skipping	O
in	O
hESCs	O
;	O
and	O
(	O
iii	O
)	O
the	O
results	O
were	O
replicable	O
in	O
at	O
least	O
two	O
experiments	O
.	O

For	O
simplicity	O
of	O
design	O
,	O
we	O
tested	O
candidates	O
predicted	O
from	O
Cyt	O
-	O
ES	O
versus	O
hCNS	O
-	O
SCns	O
.	O

Fifteen	O
REAP	O
[	O
+	O
]	O
exons	O
with	O
at	O
least	O
two	O
significant	O
outliers	O
(	O
out	O
of	O
five	O
)	O
were	O
randomly	O
chosen	O
as	O
predicted	O
alternative	O
events	O
and	O
thirty	O
-	O
five	O
exons	O
with	O
less	O
than	O
two	O
significant	O
outliers	O
were	O
randomly	O
chosen	O
as	O
constitutive	O
events	O
(	O
Table	O
S3	O
)	O
.	O

Nine	O
of	O
the	O
fifteen	O
exons	O
(	O
60	O
%	O
)	O
were	O
validated	O
as	O
AS	O
events	O
by	O
our	O
criteria	O
.	O

The	O
sensitivity	O
and	O
specificity	O
of	O
the	O
algorithm	O
at	O
the	O
cutoff	O
of	O
two	O
is	O
69	O
%	O
and	O
77	O
%	O
.	O

Increasing	O
the	O
cutoff	O
to	O
three	O
increased	O
the	O
specificity	O
to	O
85	O
%	O
,	O
with	O
a	O
slight	O
decrease	O
in	O
sensitivity	O
to	O
67	O
%	O
(	O
Figure	O
7A	O
)	O
.	O

The	O
patterns	O
of	O
AS	O
in	O
hESCs	O
were	O
similar	O
in	O
both	O
Cyt	O
-	O
ES	O
and	O
HUES6-ES	O
for	O
all	O
AS	O
events	O
validated	O
,	O
but	O
the	O
NPs	O
(	O
Cyt	O
-	O
NP	O
,	O
HUES6-NP	O
,	O
and	O
hCNS	O
-	O
SCns	O
)	O
had	O
more	O
varied	O
AS	O
.	O

The	O
pattern	O
of	O
AS	O
in	O
the	O
REAP	O
[	O
+	O
]	O
exons	O
in	O
the	O
SLK	B
(	O
serine	B
/	I
threonine	I
kinase	I
2	I
)	O
and	O
POT1	B
(	O
protection	B
of	I
telomeres	I
1	I
)	O
genes	O
showed	O
remarkable	O
agreement	O
within	O
derived	O
NPs	O
and	O
hCNS	O
-	O
SCns	O
(	O
Figure	O
7B	O
)	O
.	O

The	O
AS	O
exon	O
in	O
SLK	B
was	O
observed	O
to	O
be	O
included	O
in	O
hESCs	O
and	O
completely	O
excluded	O
in	O
NPs	O
;	O
the	O
AS	O
exon	O
in	O
the	O
POT1	B
gene	O
was	O
included	O
more	O
in	O
hESCs	O
and	O
a	O
smaller	O
isoform	O
persisted	O
in	O
NPs	O
.	O

The	O
AS	O
patterns	O
of	O
the	O
other	O
verified	O
REAP	O
[	O
+	O
]	O
exons	O
were	O
consistently	O
similar	O
in	O
hESCs	O
but	O
were	O
more	O
varied	O
in	O
the	O
NP	O
.	O

Interestingly	O
,	O
the	O
patterns	O
of	O
AS	O
in	O
the	O
derived	O
NPs	O
(	O
Cyt	O
-	O
NP	O
and	O
HUES6-NP	O
)	O
were	O
not	O
always	O
identical	O
to	O
those	O
of	O
hCNS	O
-	O
SCns	O
.	O

For	O
example	O
,	O
the	O
AS	O
exon	O
in	O
the	O
EHBP1	B
(	O
EH	B
domain	I
binding	I
protein	I
1	I
)	O
gene	O
was	O
included	O
in	O
hESCs	O
but	O
skipped	O
in	O
hCNS	O
-	O
SCns	O
,	O
and	O
both	O
isoforms	O
were	O
present	O
in	O
the	O
derived	O
NPs	O
(	O
Figure	O
7B	O
)	O
.	O

As	O
another	O
example	O
,	O
the	O
AS	O
exon	O
in	O
the	O
SORBS1	B
(	O
sorbin	B
and	I
SH3	I
domain	I
containing	I
1	I
)	O
gene	O
was	O
skipped	O
in	O
hESCs	O
and	O
included	O
in	O
hCNS	O
-	O
SCns	O
,	O
but	O
exhibited	O
an	O
intermediate	O
pattern	O
in	O
the	O
derived	O
NPs	O
.	O

However	O
,	O
in	O
some	O
cases	O
,	O
the	O
AS	O
patterns	O
in	O
the	O
derived	O
NPs	O
were	O
different	O
from	O
both	O
hESCs	O
and	O
hCNS	O
-	O
SCns	O
(	O
such	O
as	O
in	O
the	O
AS	O
exon	O
in	O
UNC84A	B
,	O
SIRT1	B
,	O
and	O
MLLT10	B
)	O
.Figure	O
7RT	O
-	O
PCR	O
Validation	O
of	O
REAP	O
-	O
Predicted	O
Alternative	O
Exons	O
(	O
A	O
)	O
Probesets	O
(	O
exons	O
)	O
were	O
considered	O
REAP	O
[	O
+	O
]	O
candidates	O
if	O
they	O
contained	O
at	O
least	O
N	O
=	O
2	O
(	O
white	O
bars	O
)	O
,	O
3	O
(	O
gray	O
bars	O
)	O
,	O
or	O
4	O
(	O
black	O
bars	O
)	O
significant	O
outliers	O
.	O

True	O
positive	O
(	O
TP	O
)	O
,	O
true	O
negative	O
(	O
TN	O
)	O
,	O
false	O
positive	O
(	O
FP	O
)	O
,	O
and	O
false	O
negative	O
(	O
FN	O
)	O
rates	O
were	O
calculated	O
from	O
RT	O
-	O
PCR	O
-	O
validated	O
REAP	O
[	O
+	O
]	O
exons	O
at	O
the	O
different	O
cutoffs	O
(	O
N	O
=	O
2	O
,	O
3	O
,	O
4	O
)	O
.	O
(	O
B	O
)	O
Nine	O
RT	O
-	O
PCR	O
validated	O
REAP	O
[	O
+	O
]	O
AS	O
events	O
in	O
hESCs	O
(	O
Cyt	O
-	O
ES	O
and	O
HUES6-ES	O
)	O
,	O
derived	O
NPs	O
(	O
Cyt	O
-	O
NP	O
and	O
HUES6-NP	O
)	O
,	O
and	O
hCNS	O
-	O
SCns	O
.	O

Arrows	O
indicate	O
the	O
larger	O
(	O
exon	O
-	O
included	O
)	O
isoforms	O
and	O
smaller	O
(	O
exon	O
-	O
skipped	O
)	O
isoforms.	O
(	O
C	O
)	O
RT	O
-	O
PCR	O
of	O
REAP	O
[	O
+	O
]	O
alternative	O
exons	O
from	O
EHBP1	B
,	O
SLK	B
,	O
and	O
RAI14	B
across	O
a	O
panel	O
of	O
human	O
tissues	O
.	O

Arrows	O
indicate	O
the	O
larger	O
(	O
exon	O
-	O
included	O
)	O
isoforms	O
and	O
smaller	O
(	O
exon	O
-	O
skipped	O
)	O
isoforms	O
.	O

First	O
,	O
given	O
three	O
independent	O
samples	O
each	O
from	O
two	O
conditions	O
,	O
we	O
concluded	O
that	O
REAP	O
was	O
able	O
to	O
identify	O
AS	O
events	O
with	O
high	O
specificity	O
but	O
with	O
moderate	O
sensitivity	O
.	O

Second	O
,	O
AS	O
events	O
in	O
hESCs	O
were	O
more	O
similar	O
,	O
whereas	O
the	O
AS	O
events	O
in	O
derived	O
NPs	O
were	O
consistent	O
with	O
or	O
intermediate	O
to	O
the	O
benchmark	O
hCNS	O
-	O
SCns	O
,	O
likely	O
reflecting	O
differences	O
in	O
the	O
cell	O
lines	O
and/or	O
differentiation	O
protocols	O
.	O

In	O
addition	O
,	O
we	O
tested	O
the	O
AS	O
patterns	O
of	O
REAP	O
[	O
+	O
]	O
exons	O
from	O
EHBP1	B
,	O
SLK	B
,	O
and	O
RAI14	B
in	O
a	O
panel	O
of	O
differentiated	O
human	O
tissues	O
(	O
Figure	O
7C	O
)	O
.	O

The	O
REAP	O
[	O
+	O
]	O
alternative	O
exon	O
in	O
the	O
RAI14	B
(	O
retinoic	B
acid	I
induced	I
14	I
)	O
gene	O
was	O
observed	O
to	O
have	O
the	O
same	O
AS	O
pattern	O
in	O
NPs	O
as	O
in	O
frontal	O
and	O
temporal	O
cortex	O
and	O
in	O
several	O
other	O
,	O
non	O
-	O
brain	O
adult	O
tissues	O
,	O
such	O
as	O
heart	O
and	O
spleen	O
.	O

The	O
AS	O
pattern	O
of	O
the	O
REAP	O
[	O
+	O
]	O
exon	O
in	O
the	O
SLK	B
gene	O
in	O
NPs	O
was	O
similar	O
to	O
most	O
differentiated	O
tissues	O
;	O
however	O
,	O
the	O
relatively	O
strong	O
inclusion	O
of	O
the	O
exon	O
in	O
hESCs	O
was	O
unique	O
.	O

Even	O
in	O
esophagus	O
,	O
kidney	O
,	O
liver	O
,	O
and	O
prostate	O
,	O
both	O
isoforms	O
were	O
present	O
.	O

The	O
relative	O
ratio	O
of	O
the	O
exon	O
-	O
included	O
to	O
exon	O
-	O
skipped	O
isoforms	O
in	O
SLK	B
likely	O
represents	O
an	O
ESC	O
-	O
specific	O
AS	O
signature	O
.	O

The	O
alternative	O
exon	O
in	O
the	O
EHBP1	B
gene	O
was	O
unusual	O
.	O

The	O
exon	O
was	O
included	O
in	O
hESCs	O
but	O
also	O
in	O
frontal	O
cortex	O
and	O
temporal	O
cortex	O
,	O
a	O
finding	O
that	O
was	O
unexpected	O
given	O
the	O
exclusion	O
of	O
the	O
exon	O
in	O
hCNS	O
-	O
SCns	O
(	O
Figure	O
7C	O
)	O
.	O

The	O
AS	O
pattern	O
in	O
hCNS	O
-	O
SCns	O
may	O
represent	O
a	O
transient	O
,	O
early	O
neuronal	O
molecular	O
change	O
.	O

Functional	O
and	O
Expression	O
Characteristics	O
of	O
REAP	O
[	O
+	O
]	O
GenesIn	O
total	O
,	O
1,500	O
genes	O
were	O
identified	O
that	O
contained	O
1,737	O
REAP	O
[	O
+	O
]	O
exons	O
,	O
68	O
%	O
of	O
which	O
lacked	O
prior	O
transcript	O
(	O
EST	O
/	O
cDNA	O
)	O
evidence	O
for	O
AS	O
.	O

To	O
determine	O
whether	O
genes	O
that	O
contained	O
REAP	O
[	O
+	O
]	O
exons	O
,	O
which	O
we	O
refer	O
to	O
as	O
REAP	O
[	O
+	O
]	O
genes	O
,	O
are	O
biased	O
toward	O
particular	O
biological	O
activities	O
,	O
REAP	O
[	O
+	O
]	O
genes	O
were	O
compared	O
to	O
a	O
set	O
of	O
REAP	O
analyzed	O
genes	O
not	O
found	O
to	O
have	O
REAP	O
[	O
+	O
]	O
exons	O
(	O
REAP	O
[	O
−	O
]	O
genes	O
)	O
.	O

A	O
Gene	O
Ontology	O
analysis	O
revealed	O
that	O
REAP	O
[	O
+	O
]	O
genes	O
are	O
enriched	O
for	O
GO	O
molecular	O
function	O
categories	O
""""	O
ATP	O
binding	O
,	O
""""	O
""""	O
helicase	B
activity	O
,	O
""""	O
""""	O
protein	O
serine	O
/	O
theronine	O
kinase	O
activity	O
,	O
""""	O
""""	O
small	B
GTPase	I
regulatory	I
/	I
interacting	I
protein	I
activity	O
,	O
""""	O
and	O
""""	O
thyroid	B
hormone	I
receptor	I
binding	O
""""	O
(	O
Table	O
1	O
)	O
.	O

In	O
terms	O
of	O
GO	O
biological	O
process	O
categories	O
,	O
REAP	O
[	O
+	O
]	O
genes	O
were	O
more	O
frequently	O
involved	O
in	O
""""	O
ubiquitin	B
cycle	O
.	O
""""	O

Similar	O
results	O
were	O
obtained	O
when	O
we	O
compared	O
REAP	O
[	O
+	O
]	O
genes	O
to	O
all	O
human	O
genes	O
that	O
did	O
not	O
contain	O
REAP	O
[	O
+	O
]	O
exons	O
(	O
Table	O
1	O
)	O
[	O
55	O
]	O
.Table	O
1Significantly	O
Enriched	O
Gene	O
Ontology	O
Terms	O
in	O
REAP	O
[	O
+	O
]	O
Genes	O
(	O
Cutoff	O
of	O
Two	O
Significant	O
""""	O
Outliers	O
""""	O
per	O
Probeset	O
)	O
Next	O
we	O
asked	O
if	O
REAP	O
[	O
+	O
]	O
genes	O
are	O
differentially	O
expressed	O
in	O
hESCs	O
compared	O
to	O
NPs	O
and	O
vice	O
versa	O
.	O

For	O
this	O
analysis	O
,	O
the	O
t	O
-	O
statistics	O
computed	O
above	O
measuring	O
the	O
enrichment	O
of	O
a	O
gene	O
in	O
hESCs	O
relative	O
to	O
NPs	O
was	O
utilized	O
for	O
only	O
REAP	O
-	O
analyzed	O
genes	O
.	O

At	O
a	O
defined	O
absolute	O
-	O
valued	O
cutoff	O
,	O
genes	O
were	O
divided	O
into	O
three	O
categories	O
:	O
""""	O
enriched	O
in	O
hESCs	O
,	O
""""	O
""""	O
enriched	O
in	O
NP	O
,	O
""""	O
or	O
""""	O
unchanged	O
""""	O
(	O
Figure	O
8A	O
)	O
.	O

Increasing	O
the	O
t	O
-	O
statistic	O
cutoff	O
from	O
one	O
to	O
five	O
,	O
the	O
fraction	O
of	O
REAP	O
[	O
+	O
]	O
genes	O
relative	O
to	O
REAP	O
-	O
analyzed	O
genes	O
remained	O
constant	O
in	O
the	O
""""	O
unchanged	O
""""	O
categories	O
(	O
Figure	O
8B	O
)	O
.	O

However	O
,	O
the	O
fraction	O
of	O
REAP	O
[	O
+	O
]	O
exons	O
decreased	O
significantly	O
in	O
""""	O
enriched	O
in	O
hESCs	O
""""	O
and	O
""""	O
enriched	O
in	O
NPs	O
""""	O
categories	O
.	O

If	O
we	O
increased	O
the	O
cutoffs	O
on	O
genes	O
that	O
were	O
randomly	O
assigned	O
as	O
REAP	O
[	O
+	O
]	O
and	O
REAP	O
[	O
−	O
]	O
,	O
controlling	O
for	O
the	O
same	O
number	O
of	O
genes	O
in	O
each	O
category	O
,	O
we	O
observed	O
that	O
the	O
fraction	O
of	O
REAP	O
[	O
+	O
]	O
exons	O
remained	O
unchanged	O
for	O
all	O
three	O
categories	O
(	O
Figure	O
8C	O
)	O
.	O

To	O
illustrate	O
,	O
at	O
a	O
cutoff	O
of	O
five	O
,	O
10	O
%	O
(	O
29	O
of	O
267	O
)	O
of	O
enriched	O
NP	O
genes	O
were	O
REAP	O
[	O
+	O
]	O
genes	O
and	O
8.8	O
%	O
(	O
102	O
of	O
1,162	O
)	O
of	O
enriched	O
hESC	O
genes	O
were	O
REAP	O
[	O
+	O
]	O
,	O
significantly	O
different	O
(	O
p	O
<	O
0.000005	O
)	O
from	O
the	O
random	O
control	O
where	O
∼14	O
%	O
of	O
enriched	O
NP	O
and	O
enriched	O
hESC	O
genes	O
were	O
REAP	O
[	O
+	O
]	O
.	O

At	O
a	O
cutoff	O
of	O
five	O
,	O
14	O
%	O
(	O
1,368	O
of	O
9,636	O
)	O
of	O
genes	O
that	O
were	O
expressed	O
at	O
similar	O
levels	O
between	O
hESCs	O
and	O
NPs	O
were	O
REAP	O
[	O
+	O
]	O
.	O

Our	O
results	O
suggested	O
that	O
a	O
strategy	O
of	O
focusing	O
on	O
differentially	O
expressed	O
genes	O
would	O
miss	O
at	O
least	O
14	O
%	O
of	O
transcriptionally	O
unchanged	O
genes	O
that	O
may	O
nevertheless	O
have	O
functional	O
AS	O
differences	O
between	O
hESCs	O
and	O
NPs	O
.	O

Figure	O
8Analysis	O
of	O
REAP	O
[	O
+	O
]	O
Genes	O
Relative	O
to	O
Transcriptional	O
Differences	O
(	O
A	O
)	O
Histogam	O
of	O
t	O
-	O
statistics	O
computed	O
from	O
gene	O
-	O
level	O
signal	O
estimates	O
measuring	O
the	O
enrichment	O
of	O
genes	O
in	O
hESC	O
and	O
in	O
NP	O
.	O

Genes	O
on	O
the	O
right	O
of	O
the	O
vertical	O
line	O
at	O
5	O
were	O
designated	O
enriched	O
in	O
hESC	O
and	O
genes	O
on	O
the	O
left	O
of	O
the	O
vertical	O
line	O
at	O
−5	O
were	O
designated	O
enriched	O
in	O
NP	O
;	O
genes	O
in	O
between	O
−5	O
and	O
5	O
were	O
designated	O
as	O
""""	O
unchanged	O
""""	O
or	O
expressed	O
similarly	O
in	O
hESC	O
and	O
NP.	O
(	O
B	O
)	O
Vertical	O
bars	O
representing	O
the	O
percentage	O
of	O
REAP	O
[	O
+	O
]	O
genes	O
out	O
of	O
all	O
genes	O
in	O
the	O
different	O
classifications	O
(	O
dashed	O
bar	O
:	O
""""	O
enriched	O
in	O
hESC	O
""""	O
;	O
black	O
filled	O
bar	O
:	O
""""	O
unchanged	O
""""	O
;	O
white	O
filled	O
bar	O
:	O
""""	O
enriched	O
in	O
NP	O
""""	O
)	O
,	O
at	O
different	O
cutoffs	O
of	O
1	O
to	O
5.	O
(	O
C	O
)	O
Set	O
of	O
genes	O
where	O
REAP	O
[	O
+	O
]	O
designation	O
was	O
randomly	O
chosen	O
.	O

Similar	O
representation	O
as	O
in	O
(	O
B	O
)	O
.	O

Conserved	O
Intronic	O
Splicing	O
Regulatory	O
Elements	O
Proximal	O
to	O
REAP	O
[	O
+	O
]	O
hESC	O
and	O
NP	O
ExonsMany	O
,	O
if	O
not	O
most	O
,	O
alternative	O
exons	O
undergo	O
cell	O
type	O
–	O
specific	O
regulation	O
by	O
the	O
binding	O
of	O
trans	O
-	O
factors	O
to	O
splicing	O
regulatory	O
cis	O
-	O
elements	O
located	O
proximal	O
to	O
or	O
within	O
the	O
exons	O
.	O

As	O
many	O
tissue	O
-	O
specific	O
splicing	O
cis	O
-	O
regulatory	O
elements	O
were	O
localized	O
in	O
intronic	O
regions	O
of	O
AS	O
exons	O
,	O
we	O
focused	O
on	O
the	O
identification	O
of	O
intronic	O
splicing	O
regulatory	O
elements	O
(	O
ISREs	O
)	O
proximal	O
to	O
REAP	O
[	O
+	O
]	O
exons	O
.	O

In	O
addition	O
,	O
we	O
wanted	O
to	O
identify	O
both	O
common	O
and	O
cell	O
type	O
–	O
specific	O
ISREs	O
.	O

Three	O
sets	O
of	O
exons	O
were	O
generated	O
:	O
(	O
i	O
)	O
REAP	O
[	O
+	O
]	O
exons	O
that	O
were	O
predicted	O
to	O
be	O
included	O
in	O
NPs	O
and	O
skipped	O
in	O
hESCs	O
(	O
REAP	O
[	O
+	O
]	O
NP	O
)	O
;	O
(	O
ii	O
)	O
REAP	O
[	O
+	O
]	O
exons	O
that	O
were	O
predicted	O
to	O
be	O
included	O
in	O
hESCs	O
and	O
skipped	O
in	O
NPs	O
(	O
REAP	O
[	O
+	O
]	O
hESC	O
)	O
;	O
and	O
(	O
iii	O
)	O
all	O
REAP	O
[	O
−	O
]	O
exons	O
.	O

Regions	O
of	O
400	O
base	O
pairs	O
flanking	O
the	O
exons	O
were	O
targeted	O
for	O
search	O
.	O

Initially	O
,	O
5-mers	O
that	O
were	O
significantly	O
enriched	O
between	O
the	O
upstream	O
and	O
downstream	O
intronic	O
regions	O
of	O
REAP	O
[	O
+	O
]	O
NP	O
and	O
REAP	O
[	O
+	O
]	O
ES	O
relative	O
to	O
REAP	O
[	O
−	O
]	O
exons	O
were	O
enumerated	O
.	O

We	O
were	O
not	O
able	O
to	O
identify	O
5-mers	O
that	O
were	O
statistically	O
significantly	O
different	O
.	O

Next	O
,	O
we	O
focused	O
on	O
splicing	O
signals	O
that	O
were	O
conserved	O
across	O
mammalian	O
genomes	O
as	O
a	O
way	O
of	O
enhancing	O
the	O
signal	O
of	O
detecting	O
functional	O
splicing	O
regulatory	O
sequences	O
[	O
66	O
]	O
.	O

Exons	O
that	O
were	O
orthologous	O
across	O
human	O
,	O
dog	O
,	O
rat	O
,	O
and	O
mouse	O
were	O
obtained	O
and	O
the	O
flanking	O
intronic	O
regions	O
were	O
aligned	O
(	O
400	O
bases	O
upstream	O
and	O
downstream	O
separately	O
;	O
Figure	O
9A	O
)	O
.	O

We	O
enumerated	O
k	O
-	O
mers	O
that	O
were	O
perfectly	O
conserved	O
across	O
all	O
four	O
genomes	O
in	O
the	O
upstream	O
(	O
and	O
downstream	O
)	O
intronic	O
regions	O
.	O

Each	O
conserved	O
k	O
-	O
mer	O
was	O
attributed	O
a	O
χ	O
score	O
representing	O
its	O
enrichment	O
in	O
a	O
set	O
of	O
exons	O
relative	O
to	O
another	O
set	O
of	O
exons	O
.	O

The	O
higher	O
the	O
score	O
,	O
the	O
more	O
frequent	O
the	O
conserved	O
k	O
-	O
mer	O
was	O
in	O
the	O
first	O
set	O
relative	O
to	O
the	O
second	O
set	O
.	O

As	O
a	O
negative	O
control	O
,	O
the	O
associations	O
between	O
REAP	O
scores	O
and	O
exons	O
were	O
shuffled	O
.	O

The	O
enrichment	O
scores	O
for	O
all	O
downstream	O
intronic	O
5-mers	O
for	O
shuffled	O
REAP	O
[	O
+	O
]	O
NP	O
versus	O
set	O
REAP	O
[	O
−	O
]	O
exons	O
(	O
x	O
-	O
axis	O
)	O
,	O
and	O
for	O
shuffled	O
REAP	O
[	O
+	O
]	O
ES	O
exons	O
versus	O
REAP	O
[	O
−	O
]	O
exons	O
(	O
y	O
-	O
axis	O
)	O
were	O
displayed	O
(	O
Figure	O
9B	O
)	O
.	O

At	O
a	O
χ	O
cutoff	O
of	O
three	O
,	O
which	O
corresponded	O
to	O
a	O
p	O
-	O
value	O
of	O
0.0015	O
,	O
the	O
majority	O
of	O
5-mers	O
were	O
not	O
significantly	O
enriched	O
in	O
either	O
shuffled	O
set	O
.	O

Confident	O
that	O
no	O
association	O
of	O
k	O
-	O
mers	O
with	O
shuffled	O
REAP	O
exons	O
were	O
found	O
;	O
we	O
repeated	O
the	O
analyses	O
for	O
upstream	O
and	O
downstream	O
intronic	O
5-mers	O
for	O
the	O
original	O
unshuffled	O
sets	O
.	O

We	O
identified	O
68	O
conserved	O
5-mers	O
enriched	O
upstream	O
of	O
REAP	O
[	O
+	O
]	O
NP	O
exons	O
;	O
and	O
34	O
5-mers	O
enriched	O
upstream	O
of	O
REAP	O
[	O
+	O
]	O
ES	O
exons	O
(	O
Figure	O
9C	O
;	O
Table	O
S4	O
)	O
.	O

Of	O
the	O
5-mers	O
that	O
were	O
significantly	O
enriched	O
upstream	O
of	O
REAP	O
[	O
+	O
]	O
NP	O
exons	O
,	O
we	O
identified	O
a	O
U	O
-	O
rich	O
motif	O
(	O
UUUUU	O
)	O
,	O
a	O
GU	O
-	O
rich	O
motif	O
(	O
GUGUG	O
)	O
,	O
and	O
a	O
CU	O
-	O
rich	O
motif	O
(	O
CCUCU	O
,	O
CUCUC	O
,	O
UCUCU	O
,	O
GCUCU	O
)	O
.	O

It	O
is	O
known	O
that	O
the	O
heterogeneous	B
ribonucleoprotein	I
C	I
(	O
hnRNP	B
C	I
)	O
binding	O
site	O
obtained	O
by	O
SELEX	O
is	O
five	O
""""	O
"U""s"	O
[	O
67	O
]	O
.	O

GU	O
-	O
rich	O
sequences	O
in	O
flanking	O
intronic	O
regions	O
were	O
shown	O
to	O
bind	O
to	O
splicing	O
factor	O
ETR-3	B
to	O
regulate	O
AS	O
[	O
68	O
]	O
.	O

CU	O
-	O
rich	O
sequences	O
were	O
shown	O
to	O
bind	O
the	O
splicing	B
factor	I
PTB	I
[	O
69	O
]	O
.	O

Of	O
the	O
5-mers	O
enriched	O
upstream	O
of	O
REAP	O
[	O
+	O
]	O
ES	O
exons	O
,	O
we	O
observed	O
CUAAC	O
,	O
which	O
resembled	O
the	O
splicing	O
branch	O
-	O
signal	O
.	O

Of	O
the	O
six	O
5-mers	O
that	O
were	O
enriched	O
upstream	O
of	O
both	O
REAP	O
[	O
+	O
]	O
NP	O
and	O
REAP	O
[	O
+	O
]	O
ES	O
exons	O
,	O
we	O
identified	O
GCAUG	O
,	O
which	O
was	O
previously	O
shown	O
to	O
be	O
an	O
intronic	O
splicing	O
cis	O
-	O
element	O
for	O
the	O
mammalian	O
fibronectin	B
and	O
calcitonin	B
/	O
CGRP	B
genes	O
[	O
70–72	O
]	O
.	O

More	O
recently	O
,	O
both	O
mammalian	O
Fox1	B
and	I
2	I
have	O
been	O
demonstrated	O
to	O
regulate	O
alternatively	O
spliced	O
exons	O
via	O
UGCAUG	O
binding	O
sites	O
in	O
neighboring	O
introns	O
in	O
neuronal	O
cell	O
cultures	O
[	O
73	O
]	O
.Figure	O
9Conserved	O
Intronic	O
cis	O
-	O
Elements	O
Enriched	O
Proximal	O
to	O
REAP	O
[	O
+	O
]	O
Alternative	O
Exons	O
(	O
A	O
)	O
Schematic	O
describing	O
the	O
enumeration	O
of	O
intronic	O
elements	O
across	O
400	O
bases	O
of	O
flanking	O
mammalian	O
introns	O
(	O
human	O
,	O
dog	O
,	O
rat	O
,	O
and	O
mouse	O
)	O
.	O

Red	O
and	O
green	O
horizontal	O
bars	O
represent	O
conserved	O
intronic	O
elements	O
and	O
nonconserved	O
elements	O
,	O
respectively	O
.	O

Internal	O
exons	O
were	O
divided	O
into	O
REAP	O
[	O
+	O
]	O
NP	O
,	O
REAP	O
[	O
+	O
]	O
ES	O
,	O
and	O
REAP	O
[	O
−	O
]	O
exons	O
.	O

The	O
χ	O
statistic	O
was	O
computed	O
to	O
represent	O
the	O
enrichment	O
of	O
conserved	O
elements	O
in	O
intronic	O
regions	O
flanking	O
REAP	O
[	O
+	O
]	O
NP	O
versus	O
REAP	O
[	O
−	O
]	O
exons	O
(	O
x	O
-	O
axis	O
)	O
,	O
and	O
REAP	O
[	O
+	O
]	O
ES	O
versus	O
REAP	O
[	O
−	O
]	O
exons	O
(	O
y	O
-	O
axis	O
)	O
.	O

The	O
sign	O
represented	O
the	O
direction	O
of	O
change	O
,	O
i.e.	O
,	O
positive	O
if	O
enriched	O
in	O
introns	O
flanking	O
REAP	O
[	O
+	O
]	O
versus	O
REAP	O
[	O
−	O
]	O
exon	O
.	O

Each	O
conserved	O
5-mer	O
was	O
associated	O
with	O
two	O
numbers	O
:	O
the	O
enrichment	O
in	O
introns	O
proximal	O
to	O
REAP	O
[	O
+	O
]	O
NP	O
versus	O
REAP	O
[	O
−	O
]	O
exons	O
(	O
x	O
-	O
axis	O
)	O
,	O
and	O
REAP	O
[	O
+	O
]	O
ES	O
versus	O
REAP	O
[	O
−	O
]	O
exons	O
(	O
y	O
-	O
axis	O
)	O
.	O
(	O
B	O
)	O
Downstream	O
intronic	O
regions	O
,	O
where	O
the	O
association	O
between	O
REAP	O
[	O
+	O
]	O
designation	O
and	O
the	O
exons	O
was	O
shuffled.	O
(	O
C	O
)	O
Upstream	O
intronic	O
regions	O
.	O

Circled	O
5-mers	O
in	O
the	O
upper	O
right	O
quadrant	O
represent	O
conserved	O
5-mers	O
enriched	O
in	O
the	O
upstream	O
intronic	O
regions	O
of	O
REAP	O
[	O
+	O
]	O
NP	O
and	O
REAP	O
[	O
+	O
]	O
ES	O
exons.	O
(	O
D	O
)	O

Downstream	O
intronic	O
regions	O
.	O

Circled	O
5-mers	O
in	O
the	O
upper	O
right	O
quadrant	O
represent	O
conserved	O
5-mers	O
enriched	O
in	O
the	O
downstream	O
intronic	O
regions	O
of	O
REAP	O
[	O
+	O
]	O
NP	O
and	O
REAP	O
[	O
+	O
]	O
ES	O
exons	O
.	O

Eighteen	O
conserved	O
5-mers	O
were	O
significantly	O
enriched	O
in	O
the	O
downstream	O
introns	O
of	O
REAP	O
[	O
+	O
]	O
ES	O
exons	O
;	O
and	O
76	O
5-mers	O
were	O
enriched	O
downstream	O
of	O
REAP	O
[	O
+	O
]	O
NP	O
exons	O
(	O
Table	O
S4	O
,	O
Figure	O
9D	O
)	O
.	O

We	O
identified	O
a	O
motif	O
CUCAU	O
resembling	O
the	O
Nova	B
binding	O
site	O
YCAY	O
[	O
74	O
]	O
,	O
and	O
a	O
G	O
-	O
rich	O
motif	O
(	O
AGGGG	O
,	O
GGGGA	O
,	O
GGGGC	O
,	O
GGGGG	O
,	O
GGGGU	O
)	O
enriched	O
in	O
the	O
introns	O
downstream	O
of	O
REAP	O
[	O
+	O
]	O
ES	O
exons	O
.	O

G	O
-	O
rich	O
motifs	O
had	O
previously	O
been	O
shown	O
to	O
be	O
part	O
of	O
a	O
bipartite	O
signal	O
that	O
silences	O
AS	O
exons	O
[	O
75	O
]	O
.	O

Of	O
the	O
five	O
5-mers	O
that	O
were	O
enriched	O
downstream	O
of	O
both	O
REAP	O
[	O
+	O
]	O
NP	O
and	O
REAP	O
[	O
+	O
]	O
ES	O
exons	O
,	O
GCAUG	O
and	O
a	O
U	O
-	O
rich	O
motif	O
(	O
UUUUU	O
)	O
were	O
identified	O
.	O

We	O
concluded	O
that	O
potential	O
ISREs	O
were	O
enriched	O
proximal	O
to	O
a	O
subset	O
of	O
REAP	O
[	O
+	O
]	O
exons	O
;	O
in	O
particular	O
,	O
the	O
Fox1	B
/	I
2	I
binding	O
site	O
GCUAG	O
may	O
play	O
a	O
regulatory	O
role	O
in	O
controlling	O
AS	O
events	O
in	O
hESCs	O
and	O
NPs	O
.	O

The	O
ability	O
of	O
ESCs	O
to	O
generate	O
all	O
three	O
embryonic	O
germ	O
layers	O
has	O
raised	O
the	O
exciting	O
possibility	O
that	O
hESCs	O
may	O
become	O
an	O
unlimited	O
source	O
of	O
cells	O
for	O
transplantation	O
therapies	O
involving	O
organs	O
or	O
tissues	O
such	O
as	O
the	O
liver	O
,	O
pancreas	O
,	O
blood	O
,	O
and	O
nervous	O
system	O
,	O
and	O
become	O
tools	O
to	O
explore	O
the	O
molecular	O
mechanisms	O
of	O
human	O
development	O
.	O

Despite	O
such	O
interests	O
,	O
relatively	O
little	O
is	O
understood	O
about	O
the	O
molecular	O
mechanisms	O
defining	O
their	O
pluripotency	O
and	O
the	O
molecular	O
changes	O
important	O
for	O
hESCs	O
to	O
differentiate	O
into	O
specific	O
cell	O
types	O
.	O

To	O
understand	O
these	O
events	O
,	O
protocols	O
are	O
still	O
being	O
developed	O
to	O
differentiate	O
ESCs	O
into	O
a	O
variety	O
of	O
lineages	O
.	O

Of	O
particular	O
biomedical	O
interest	O
is	O
in	O
the	O
capacity	O
of	O
hESCs	O
to	O
be	O
differentiated	O
into	O
a	O
self	O
-	O
renewing	O
population	O
of	O
NPs	O
that	O
can	O
be	O
then	O
further	O
coaxed	O
into	O
a	O
variety	O
of	O
neuronal	O
subtypes	O
,	O
such	O
as	O
dopaminergic	O
neurons	O
that	O
are	O
important	O
in	O
the	O
treatment	O
of	O
Parkinson	O
disease	O
or	O
cholinergic	O
neurons	O
for	O
ALS	O
(	O
amyotrophic	O
lateral	O
sclerosis	O
)	O
.	O

While	O
many	O
microarray	O
studies	O
have	O
explored	O
molecular	O
differences	O
between	O
hESCs	O
and	O
derived	O
NPs	O
,	O
most	O
,	O
if	O
not	O
all	O
,	O
have	O
focused	O
on	O
transcriptional	O
changes	O
.	O

These	O
studies	O
have	O
largely	O
ignored	O
intermediate	O
RNA	O
processing	O
events	O
prior	O
to	O
and	O
during	O
translation	O
.	O

In	O
recent	O
years	O
,	O
AS	O
has	O
gained	O
momentum	O
as	O
being	O
important	O
in	O
development	O
,	O
apoptosis	O
,	O
and	O
cancer	O
.	O

REAP	O
,	O
a	O
regression	O
-	O
based	O
method	O
for	O
analyzing	O
exon	O
array	O
data	O
was	O
introduced	O
,	O
and	O
was	O
applied	O
to	O
discover	O
AS	O
events	O
in	O
hESCs	O
,	O
their	O
derived	O
NPs	O
,	O
and	O
in	O
hCNS	O
-	O
SCns	O
.	O

REAP	O
was	O
based	O
on	O
the	O
assumptions	O
that	O
most	O
exons	O
in	O
the	O
gene	O
of	O
interest	O
and	O
in	O
the	O
genome	O
are	O
constitutively	O
spliced	O
and	O
that	O
outliers	O
in	O
a	O
linear	O
pairwise	O
comparison	O
of	O
the	O
signal	O
estimates	O
for	O
probesets	O
in	O
a	O
gene	O
could	O
be	O
detected	O
using	O
a	O
robust	O
regression	O
-	O
based	O
approach	O
.	O

REAP	O
predictions	O
were	O
found	O
to	O
correlate	O
well	O
with	O
transcript	O
-	O
based	O
methods	O
for	O
identifying	O
alternative	O
exons	O
,	O
which	O
interestingly	O
suggested	O
that	O
current	O
databases	O
of	O
transcript	O
information	O
,	O
albeit	O
not	O
specifically	O
enriched	O
for	O
hESC	O
or	O
NPs	O
,	O
in	O
aggregate	O
are	O
nevertheless	O
predictive	O
of	O
AS	O
events	O
in	O
hESC	O
and	O
NP	O
.	O

In	O
addition	O
,	O
REAP	O
[	O
+	O
]	O
exons	O
were	O
also	O
enriched	O
for	O
ACEScan	O
-	O
predicted	O
evolutionarily	O
conserved	O
exons	O
[	O
55	O
]	O
.	O

As	O
ACEScan	O
utilized	O
a	O
different	O
set	O
of	O
information	O
from	O
REAP	O
,	O
the	O
agreement	O
between	O
both	O
algorithms	O
served	O
to	O
further	O
validate	O
the	O
predicted	O
alternative	O
exons	O
.	O

Additional	O
studies	O
in	O
mouse	O
ESCs	O
and	O
neural	O
derivatives	O
will	O
be	O
necessary	O
to	O
determine	O
if	O
these	O
AS	O
events	O
are	O
indeed	O
preserved	O
in	O
these	O
analogous	O
and	O
orthologous	O
cell	O
types	O
.	O

Our	O
finding	O
that	O
only	O
a	O
minority	O
of	O
AS	O
events	O
was	O
common	O
between	O
various	O
hESC	O
to	O
NP	O
comparisons	O
is	O
intriguing	O
.	O

A	O
possible	O
explanation	O
is	O
that	O
the	O
cell	O
lines	O
were	O
not	O
only	O
genetically	O
different	O
,	O
but	O
were	O
also	O
exposed	O
to	O
different	O
isolation	O
and	O
culture	O
conditions	O
.	O

In	O
addition	O
,	O
the	O
different	O
differentiation	O
protocols	O
established	O
as	O
optimal	O
for	O
generating	O
Nestin	B
and	O
Sox1	B
positive	O
neural	O
precursors	O
may	O
lead	O
to	O
vastly	O
different	O
molecular	O
changes	O
.	O

It	O
is	O
likely	O
that	O
post	O
-	O
transcriptional	O
changes	O
such	O
as	O
AS	O
may	O
be	O
more	O
variable	O
despite	O
the	O
cells	O
being	O
at	O
acknowledged	O
""""	O
end	O
-	O
points	O
""""	O
defined	O
by	O
a	O
limited	O
set	O
of	O
immunohistochemical	O
markers	O
.	O

Our	O
results	O
are	O
consistent	O
with	O
a	O
recent	O
study	O
that	O
showed	O
that	O
while	O
two	O
well	O
-	O
established	O
hESC	O
lines	O
differentiate	O
into	O
functional	O
neurons	O
,	O
the	O
two	O
lines	O
exhibited	O
distinct	O
differentiation	O
potentials	O
,	O
suggesting	O
that	O
some	O
preprogramming	O
had	O
occurred	O
[	O
76	O
]	O
.	O

In	O
particular	O
,	O
microRNA	O
profiling	O
revealed	O
significant	O
expression	O
differences	O
between	O
the	O
two	O
hESC	O
lines	O
,	O
suggesting	O
that	O
microRNAs	O
,	O
known	O
post	O
-	O
transcriptional	O
regulators	O
,	O
may	O
sway	O
the	O
differentiation	O
properties	O
of	O
the	O
cell	O
lines	O
[	O
76	O
]	O
.	O

We	O
postulated	O
that	O
AS	O
events	O
may	O
serve	O
also	O
to	O
bias	O
the	O
differentiation	O
spectrum	O
of	O
the	O
cells	O
,	O
an	O
important	O
avenue	O
for	O
future	O
work	O
.	O

Experimental	O
validation	O
of	O
REAP	O
[	O
+	O
]	O
exons	O
suggested	O
a	O
high	O
specificity	O
at	O
the	O
expense	O
of	O
relatively	O
moderate	O
sensitivity	O
.	O

We	O
believe	O
that	O
the	O
high	O
FP	O
rates	O
may	O
arise	O
from	O
cross	O
-	O
hybridization	O
effects	O
that	O
remained	O
unaccounted	O
for	O
.	O

However	O
,	O
our	O
specificity	O
of	O
77	O
%	O
at	O
the	O
cutoff	O
of	O
two	O
significant	O
outliers	O
per	O
probeset	O
allowed	O
us	O
to	O
estimate	O
that	O
at	O
least	O
1,336	O
of	O
1,737	O
REAP	O
[	O
+	O
]	O
exons	O
were	O
true	O
AS	O
events	O
that	O
changed	O
during	O
neuronal	O
differentiation	O
of	O
hESC	O
cells	O
,	O
and/or	O
were	O
different	O
between	O
endogeneous	O
NPs	O
and	O
hESC	O
.	O

On	O
average	O
,	O
7	O
%	O
of	O
all	O
human	O
exons	O
have	O
been	O
estimated	O
by	O
transcript	O
data	O
to	O
undergo	O
AS	O
;	O
thus	O
REAP	O
's	O
validation	O
rate	O
of	O
60	O
%	O
at	O
the	O
cutoff	O
of	O
two	O
is	O
73-fold	O
(	O
60	O
/	O
7	O
)	O
higher	O
than	O
expected	O
.	O

In	O
addition	O
,	O
we	O
validated	O
nine	O
novel	O
AS	O
events	O
that	O
distinguish	O
hESCs	O
and	O
NPs	O
.	O

Consistent	O
with	O
our	O
computational	O
results	O
,	O
we	O
observed	O
that	O
the	O
AS	O
patterns	O
in	O
hCNS	O
-	O
SCns	O
were	O
not	O
always	O
similar	O
to	O
those	O
of	O
the	O
derived	O
NPs	O
.	O

It	O
was	O
important	O
to	O
point	O
out	O
that	O
while	O
transcriptional	O
expression	O
of	O
these	O
genes	O
did	O
not	O
distinguish	O
these	O
cells	O
from	O
one	O
another	O
,	O
in	O
several	O
instances	O
the	O
REAP	O
-	O
predicted	O
AS	O
event	O
was	O
able	O
to	O
separate	O
derived	O
NPs	O
and	O
hCNS	O
-	O
SCns	O
.	O

A	O
notable	O
exception	O
was	O
the	O
alternative	O
exon	O
in	O
the	O
SLK	B
gene	O
,	O
encoding	O
a	O
serine	B
/	I
threonine	I
kinase	I
protein	O
,	O
which	O
was	O
commonly	O
included	O
in	O
both	O
hESCs	O
,	O
i.e.	O
,	O
the	O
exon	O
-	O
excluded	O
isoform	O
was	O
not	O
present	O
in	O
hESCs	O
compared	O
to	O
NPs	O
,	O
as	O
well	O
as	O
in	O
a	O
variety	O
of	O
differentiated	O
tissues	O
.	O

Closer	O
inspection	O
of	O
the	O
REAP	O
[	O
+	O
]	O
-validated	O
AS	O
exon	O
in	O
the	O
SLK	B
gene	O
revealed	O
strong	O
conservation	O
in	O
the	O
intronic	O
region	O
flanking	O
the	O
exon	O
,	O
a	O
hallmark	O
feature	O
of	O
evolutionarily	O
conserved	O
AS	O
exons	O
[	O
55,77,78	O
]	O
.	O

A	O
study	O
analyzing	O
the	O
expression	O
patterns	O
of	O
the	O
SLK	B
gene	O
suggested	O
a	O
potential	O
functional	O
role	O
during	O
embryonic	O
development	O
and	O
in	O
the	O
adult	O
central	O
nervous	O
system	O
[	O
79	O
]	O
;	O
however	O
,	O
to	O
our	O
knowledge	O
,	O
our	O
identification	O
of	O
the	O
SLK	B
alternative	O
exon	O
is	O
the	O
first	O
report	O
of	O
a	O
hESC	O
-	O
biased	O
AS	O
pattern	O
during	O
neuronal	O
differentiation	O
and	O
across	O
a	O
myriad	O
of	O
differentiated	O
tissues	O
.	O

In	O
agreement	O
,	O
GO	O
analysis	O
suggested	O
that	O
genes	O
containing	O
REAP	O
[	O
+	O
]	O
exons	O
were	O
enriched	O
in	O
serine	B
/	I
threonine	I
kinase	I
activity	O
,	O
of	O
which	O
SLK	B
is	O
a	O
family	O
member	O
.	O

Future	O
work	O
will	O
be	O
required	O
to	O
study	O
the	O
impact	O
of	O
AS	O
in	O
these	O
genes	O
in	O
hESCs	O
and	O
NPs	O
.	O

We	O
predict	O
it	O
is	O
unlikely	O
that	O
the	O
alternative	O
exon	O
in	O
the	O
SLK	B
gene	O
is	O
the	O
only	O
case	O
common	O
across	O
hESC	O
and	O
different	O
from	O
differentiated	O
tissues	O
,	O
but	O
further	O
studies	O
will	O
be	O
necessary	O
to	O
identify	O
other	O
hESC	O
-	O
specific	O
exons	O
.	O

REAP	O
[	O
+	O
]	O
exons	O
were	O
underrepresented	O
in	O
genes	O
that	O
were	O
differentially	O
transcriptionally	O
regulated	O
in	O
hESCs	O
and	O
NPs	O
.	O

Our	O
results	O
act	O
as	O
a	O
reminder	O
that	O
focusing	O
only	O
on	O
genes	O
that	O
are	O
differentially	O
expressed	O
will	O
overlook	O
RNA	O
processing	O
events	O
that	O
may	O
be	O
biologically	O
relevant	O
to	O
the	O
system	O
of	O
interest	O
.	O

Finally	O
,	O
we	O
identified	O
potential	O
cis	O
-	O
regulatory	O
intronic	O
elements	O
conserved	O
and	O
enriched	O
proximal	O
to	O
the	O
REAP	O
[	O
+	O
]	O
exons	O
.	O

In	O
particular	O
,	O
the	O
FOX1	B
/	I
2	I
binding	O
site	O
,	O
GCUAG	O
,	O
was	O
conserved	O
and	O
enriched	O
in	O
the	O
flanking	O
introns	O
of	O
a	O
subset	O
of	O
REAP	O
[	O
+	O
]	O
exons	O
.	O

Further	O
studies	O
will	O
be	O
required	O
to	O
explore	O
the	O
importance	O
of	O
FOX1	B
family	O
members	O
in	O
early	O
neuronal	O
differentiation	O
.	O

In	O
conclusion	O
,	O
our	O
introduction	O
of	O
REAP	O
and	O
its	O
application	O
to	O
identifying	O
AS	O
events	O
has	O
revealed	O
new	O
and	O
unanticipated	O
insights	O
into	O
hESC	O
biology	O
and	O
their	O
transition	O
to	O
NP	O
cells	O
.	O

Collectively	O
,	O
these	O
exons	O
represent	O
a	O
set	O
of	O
molecular	O
changes	O
that	O
are	O
likely	O
to	O
be	O
important	O
for	O
studying	O
human	O
neural	O
differentiation	O
with	O
applications	O
in	O
neuronal	O
regenerative	O
medicine	O
.	O

Maintenance	O
and	O
differentiation	O
of	O
hESCs	O
and	O
hCNS	O
-	O
SCns.hESC	O
line	O
Cy203	O
(	O
Cythera	O
)	O
was	O
cultured	O
as	O
previously	O
described	O
[	O
12	O
]	O
.	O

To	O
differentiate	O
into	O
neuroepithelial	O
precursor	O
cells	O
,	O
colonies	O
were	O
manually	O
isolated	O
from	O
mouse	O
embryonic	O
fibroblasts	O
(	O
MEFs	O
)	O
and	O
cut	O
in	O
small	O
pieces	O
.	O

These	O
pieces	O
were	O
transferred	O
to	O
a	O
T75	O
flask	O
with	O
hESCs	O
differentiation	O
media	O
(	O
same	O
hESC	O
medium	O
but	O
10	O
%	O
KSR	B
and	O
no	O
FGF-2	B
)	O
.	O

Medium	O
was	O
changed	O
the	O
next	O
day	O
by	O
transferring	O
the	O
floating	O
hESC	O
aggregates	O
to	O
a	O
new	O
flask	O
.	O

After	O
culturing	O
for	O
a	O
week	O
,	O
the	O
hESC	O
cell	O
aggregates	O
formed	O
mature	O
embroid	O
bodies	O
(	O
EBs	O
;	O
∼10	O
um	O
round	O
clusters	O
with	O
dark	O
centers	O
)	O
.	O

EBs	O
were	O
plated	O
on	O
a	O
coated	O
10-cm	O
dish	O
in	O
hESC	O
differentiation	O
media	O
.	O

The	O
next	O
day	O
,	O
the	O
medium	O
was	O
changed	O
to	O
DMEM	O
/	O
F12	O
supplemented	O
with	O
ITS	B
and	O
fibronectin	B
.	O

Medium	O
was	O
changed	O
every	O
other	O
day	O
for	O
a	O
week	O
or	O
until	O
the	O
cells	O
formed	O
rosette	O
-	O
like	O
columnar	O
structures	O
that	O
were	O
isolated	O
manually	O
.	O

These	O
structures	O
were	O
then	O
transferred	O
to	O
coated	O
dishes	O
in	O
neural	O
induction	O
medium	O
(	O
DMEM	O
/	O
F12	O
supplemented	O
with	O
N2	O
and	O
FGF-2	B
)	O
for	O
a	O
week	O
.	O

Elongated	O
single	O
cells	O
were	O
separated	O
from	O
leftover	O
aggregates	O
using	O
non	O
-	O
enzymatic	O
dissociation	O
.	O

After	O
one	O
to	O
two	O
passages	O
,	O
the	O
cells	O
formed	O
a	O
monolayer	O
of	O
homogeneous	O
NPs	O
(	O
negative	O
for	O
Sox1	B
immunostaining	O
)	O
.	O

Upon	O
confluence	O
,	O
cells	O
will	O
form	O
neurospheres	O
that	O
can	O
also	O
be	O
isolated	O
from	O
the	O
neuroepithelial	O
precursor	O
cells	O
(	O
positive	O
for	O
Sox1	B
immunostaining	O
)	O
.	O

At	O
any	O
of	O
these	O
two	O
stages	O
,	O
pan	O
-	O
neuronal	O
differentiation	O
can	O
be	O
achieved	O
after	O
three	O
to	O
four	O
weeks	O
.	O

hESC	O
line	O
HUES6	O
was	O
cultured	O
on	O
MEF	O
feeders	O
as	O
previously	O
described	O
(	O
http://www.mcb.harvard.edu/melton/hues/	O
)	O
or	O
on	O
GFR	O
matrigel	O
coated	O
plates	O
.	O

Cells	O
grown	O
on	O
matrigel	O
were	O
grown	O
in	O
MEF	O
-	O
conditioned	O
medium	O
and	O
FGF-2	B
was	O
used	O
at	O
20	O
ng	O
/	O
mL	O
instead	O
of	O
10	O
ng	O
/	O
mL	O
for	O
cells	O
grown	O
on	O
MEFs	O
.	O

To	O
differentiate	O
neuroepithelial	O
precursors	O
,	O
colonies	O
were	O
removed	O
by	O
treatment	O
with	O
collagenase	B
IV	I
(	O
Sigma	O
)	O
and	O
washed	O
three	O
times	O
in	O
growth	O
media	O
.	O

The	O
pieces	O
of	O
colonies	O
were	O
resuspended	O
in	O
HUES	O
growth	O
media	O
without	O
FGF2	B
in	O
an	O
uncoated	O
bacterial	O
Petri	O
dish	O
to	O
form	O
EBs	O
.	O

After	O
one	O
week	O
,	O
EBs	O
were	O
plated	O
on	O
polyornathine	O
/	O
laminin	B
coated	O
plates	O
in	O
DMEM	O
/	O
F12	O
supplemented	O
with	O
N2	O
and	O
FGF2	B
.	O

Rosette	O
structures	O
were	O
manually	O
collected	O
and	O
enzymatically	O
dissociated	O
with	O
TryPLE	O
(	O
Invitrogen	O
)	O
,	O
plated	O
on	O
polyornathine	O
/	O
laminin	O
coated	O
plates	O
,	O
and	O
grown	O
in	O
DMEM	O
/	O
F12	O
supplemented	O
with	O
N2	O
and	O
B27-RA	B
and	O
20	O
ng	O
/	O
mL	O
FGF-2	B
.	O

Cells	O
could	O
be	O
grown	O
as	O
a	O
monolayer	O
for	O
up	O
to	O
at	O
least	O
ten	O
passages	O
.	O

Cells	O
were	O
Sox1	B
and	O
nestin	B
positive	O
and	O
readily	O
differentiated	O
into	O
neurons	O
upon	O
withdrawal	O
of	O
FGF-2	B
.	O

Human	O
central	O
nervous	O
system	O
stem	O
cell	O
line	O
FBR1664	O
(	O
StemCells	O
)	O
which	O
is	O
referred	O
to	O
as	O
hCNS	O
-	O
SCns	O
in	O
the	O
main	O
text	O
was	O
cultured	O
as	O
previously	O
described	O
[	O
23	O
]	O
.	O

The	O
cells	O
were	O
cultured	O
in	O
medium	O
consisting	O
of	O
Ex	O
Vivo	O
15	O
(	O
BioWhittaker	O
)	O
medium	O
with	O
N2	O
supplement	O
(	O
GIBCO	O
)	O
,	O
FGF2	B
(	O
20	O
ng	O
/	O
mL	O
)	O
,	O
epidermal	B
growth	I
factor	I
(	O
20	O
ng	O
/	O
mL	O
)	O
,	O
lymphocyte	B
inhibitory	I
factor	I
(	O
10	O
ng	O
/	O
mL	O
)	O
,	O
0.2	O
mg	O
/	O
ml	O
heparin	O
,	O
and	O
60	O
ug	O
/	O
mL	O
N	O
-	O
acetylcysteine	O
.	O

Cultures	O
were	O
fed	O
weekly	O
and	O
passaged	O
at	O
∼two	O
to	O
three	O
weeks	O
using	O
collagenases	B
(	O
Roche	O
)	O
.	O

The	O
following	O
antibodies	O
and	O
corresponding	O
dilutions	O
were	O
utilized	O
for	O
the	O
immunohistochemical	O
analysis	O
of	O
marker	O
genes	O
in	O
Cyt	O
-	O
ES	O
and	O
HUES6-ES	O
:	O
Sox2	B
(	O
Chemicon	O
,	O
1:500	O
)	O
,	O
Oct4	B
(	O
Santa	O
Cruz	O
,	O
1:500	O
)	O
,	O
Sox1	B
(	O
Chemicon	O
,	O
1:500	O
)	O
,	O
Nestin	B
(	O
Pharmingen	O
,	O
1:250	O
)	O
;	O
hCNS	O
-	O
SCns	O
:	O
Sox2	B
(	O
Chemicon	O
,	O
1:200	O
)	O
,	O
Nestin	B
(	O
Chemicon	O
,	O
1:200	O
)	O
.	O

RNA	O
preparation	O
and	O
array	O
hybridization	O
.	O

Total	O
RNA	O
from	O
cells	O
was	O
processed	O
as	O
follows	O
.	O

Cells	O
were	O
lysed	O
in	O
1	O
mL	O
of	O
RNA	O
-	O
bee	O
(	O
Teltest	O
)	O
.	O

The	O
RNA	O
was	O
isolated	O
by	O
chloroform	O
extraction	O
of	O
the	O
aqueous	O
phase	O
,	O
followed	O
by	O
isopropanol	O
precipitation	O
as	O
per	O
the	O
manufacturer	O
's	O
instructions	O
.	O

The	O
precipitated	O
RNA	O
was	O
washed	O
in	O
75	O
%	O
ethanol	O
and	O
eluted	O
with	O
DEPC	O
-	O
treated	O
water	O
.	O

Five	O
ug	O
of	O
RNA	O
was	O
treated	O
with	O
RQ1	O
DNAase	B
(	O
Promega	O
)	O
according	O
to	O
the	O
manufacturer	O
's	O
instructions	O
.	O

One	O
ug	O
of	O
total	O
RNA	O
for	O
each	O
sample	O
was	O
processed	O
using	O
the	O
Affymetrix	O
GeneChip	O
Whole	O
Transcript	O
Sense	O
Target	O
Labeling	O
Assay	O
(	O
Affymetrix	O
)	O
.	O

Ribosomal	O
RNA	O
was	O
reduced	O
with	O
the	O
RiboMinus	O
Kit	O
(	O
Invitrogen	O
)	O
.	O

Target	O
material	O
was	O
prepared	O
using	O
commercially	O
available	O
Affymetrix	O
GeneChip	O
WT	O
cDNA	O
Synthesis	O
Kit	O
,	O
WT	O
cDNA	O
Amplification	O
Kit	O
,	O
and	O
WT	O
Terminal	O
Labeling	O
Kit	O
(	O
Affymetrix	O
)	O
as	O
per	O
manufacturer	O
's	O
instructions	O
.	O

Hybridization	O
cocktails	O
containing	O
∼5	O
ug	O
of	O
fragmented	O
and	O
labeled	O
DNA	O
target	O
were	O
prepared	O
and	O
applied	O
to	O
GeneChip	O
Human	O
Exon	O
1.0	O
ST	O
arrays	O
.	O

Hybridization	O
was	O
performed	O
for	O
16	O
hours	O
using	O
the	O
Fluidics	O
450	O
station	O
.	O

Arrays	O
were	O
scanned	O
using	O
the	O
Affymetrix	O
3000	O
7	O
G	O
scanner	O
and	O
GeneChip	O
Operating	O
Software	O
version	O
1.4	O
to	O
produce	O
.CEL	O
intensity	O
files	O
.	O

Detection	O
of	O
AS	O
by	O
RT	O
-	O
PCR.cDNAs	O
were	O
generated	O
from	O
total	O
RNA	O
with	O
Superscript	O
III	O
reverse	B
transcriptase	I
(	O
Invitrogen	O
)	O
.	O

PCR	O
reactions	O
were	O
performed	O
with	O
primer	O
pairs	O
designed	O
for	O
AS	O
targets	O
(	O
annealing	O
at	O
58	O
°	O
C	O
and	O
amplification	O
for	O
30	O
or	O
35	O
cycles	O
)	O
.	O

PCR	O
products	O
were	O
resolved	O
on	O
either	O
1.5	O
%	O
or	O
3	O
%	O
agarose	O
gel	O
in	O
TBE	O
.	O

The	O
Ethidium	O
Bromide	O
-	O
stained	O
gels	O
were	O
scanned	O
with	O
Typhoon	O
8600	O
scanner	O
(	O
Molecular	O
Dynamics	O
)	O
for	O
quantification	O
.	O

The	O
number	O
of	O
true	O
positives	O
(	O
TP	O
;	O
false	O
negatives	O
,	O
FN	O
)	O
was	O
computed	O
as	O
the	O
number	O
of	O
REAP	O
[	O
+	O
]	O
(	O
REAP	O
[	O
−	O
]	O
)	O
exons	O
that	O
were	O
validated	O
by	O
RT	O
-	O
PCR	O
as	O
AS	O
.	O

The	O
number	O
of	O
true	O
negatives	O
(	O
TN	O
;	O
or	O
FPs	O
)	O
was	O
computed	O
as	O
the	O
number	O
of	O
REAP	O
[	O
−	O
]	O
(	O
REAP	O
[	O
+	O
]	O
)	O
exons	O
that	O
were	O
validated	O
by	O
RT	O
-	O
PCR	O
as	O
constitutively	O
spliced	O
.	O

The	O
true	O
(	O
false	O
)	O
positive	O
rate	O
was	O
computed	O
as	O
TP	O
(	O
FP	O
)	O
divided	O
by	O
the	O
total	O
number	O
of	O
REAP	O
[	O
+	O
]	O
exons	O
in	O
the	O
experimentally	O
validated	O
set	O
.	O

The	O
true	O
(	O
false	O
)	O
negative	O
rate	O
was	O
computed	O
as	O
the	O
TN	O
(	O
FN	O
)	O
divided	O
by	O
the	O
total	O
number	O
of	O
REAP	O
[	O
−	O
]	O
exons	O
in	O
the	O
experimentally	O
validated	O
set	O
.	O

Sensitivity	O
was	O
computed	O
as	O
TP	O
/	O
(	O
TP+FN	O
)	O
and	O
specificity	O
was	O
computed	O
as	O
TN	O
/	O
(	O
FP+TN	O
)	O
.	O

Sequence	O
databases	O
.	O

Genome	O
sequences	O
of	O
human	O
(	O
hg17	O
)	O
,	O
dog	O
(	O
canFam1	O
)	O
,	O
rat	O
(	O
rn3	O
)	O
,	O
and	O
mouse	O
(	O
mm5	O
)	O
were	O
obtained	O
from	O
UCSC	O
,	O
as	O
were	O
the	O
whole	O
-	O
genome	O
MULTIZ	O
alignments	O
[	O
80	O
]	O
.	O

The	O
lists	O
of	O
known	O
human	O
genes	O
(	O
knownGene	O
containing	O
43,401	O
entries	O
)	O
and	O
known	O
isoforms	O
(	O
knownIsoforms	O
containing	O
43,286	O
entries	O
in	O
21,397	O
unique	O
isoform	O
clusters	O
)	O
with	O
annotated	O
exon	O
alignments	O
to	O
human	O
hg17	O
genomic	O
sequence	O
were	O
processed	O
as	O
follows	O
.	O

Known	O
genes	O
that	O
were	O
mapped	O
to	O
different	O
isoform	O
clusters	O
were	O
discarded	O
.	O

All	O
mRNAs	O
aligned	O
to	O
hg17	O
that	O
were	O
greater	O
than	O
300	O
bases	O
long	O
were	O
clustered	O
together	O
with	O
the	O
known	O
isoforms	O
.	O

Genes	O
containing	O
less	O
than	O
three	O
exons	O
were	O
removed	O
from	O
further	O
consideration	O
.	O

A	O
total	O
of	O
2.7	O
million	O
spliced	O
ESTs	O
were	O
mapped	O
onto	O
the	O
17,478	O
high	O
-	O
quality	O
genes	O
to	O
infer	O
AS	O
.	O

Exons	O
with	O
canonical	O
splice	O
signals	O
(	O
GT	O
-	O
AG	O
,	O
AT	O
-	O
AC	O
,	O
GC	O
-	O
AG	O
)	O
were	O
retained	O
,	O
resulting	O
in	O
a	O
total	O
of	O
213,736	O
exons	O
.	O

Of	O
these	O
,	O
197,262	O
(	O
92	O
%	O
of	O
all	O
exons	O
)	O
were	O
constitutive	O
exons	O
,	O
13,934	O
exons	O
(	O
7	O
%	O
)	O
had	O
evidence	O
of	O
exon	O
-	O
skipping	O
,	O
1,615	O
(	O
1	O
%	O
)	O
exons	O
were	O
mutually	O
exclusive	O
alternative	O
events	O
,	O
5,930	O
(	O
3	O
%	O
)	O
exons	O
had	O
alternative	O
3′	O
splice	O
sites	O
,	O
5,181	O
(	O
2	O
%	O
)	O
exons	O
had	O
alternative	O
5′	O
splice	O
sites	O
,	O
and	O
175	O
(	O
<	O
1	O
%	O
)	O
exons	O
overlapped	O
another	O
exon	O
,	O
but	O
did	O
not	O
fall	O
into	O
the	O
above	O
classifications	O
.	O

A	O
total	O
of	O
324,139	O
probesets	O
from	O
the	O
Affymetrix	O
Human	O
Exon	O
1.0	O
ST	O
array	O
were	O
mapped	O
to	O
208,422	O
human	O
exons	O
,	O
representing	O
17,431	O
genes	O
.	O

These	O
probesets	O
were	O
used	O
to	O
derive	O
gene	O
and	O
exon	O
-	O
level	O
signal	O
estimates	O
from	O
the	O
CEL	O
files	O
.	O

The	O
four	O
-	O
way	O
mammalian	O
(	O
four	O
-	O
mammal	O
)	O
whole	O
-	O
genome	O
alignment	O
(	O
hg17	O
,	O
canFam1	O
,	O
mm5	O
,	O
rn3	O
)	O
was	O
extracted	O
from	O
the	O
eight	O
-	O
way	O
vertebrate	O
MULTIZ	O
alignments	O
(	O
hg17	O
,	O
panTrol1	O
,	O
mm5	O
,	O
rn3	O
,	O
canFam1	O
,	O
galGal2	O
,	O
fr1	O
,	O
danRer1	O
)	O
obtained	O
from	O
the	O
UCSC	O
Genome	O
Browser	O
.	O

Four	O
-	O
way	O
mammal	O
alignments	O
were	O
extracted	O
for	O
all	O
internal	O
exons	O
,	O
and	O
400	O
bases	O
of	O
flanking	O
intronic	O
sequence	O
,	O
resulting	O
in	O
a	O
total	O
of	O
161,731	O
conserved	O
internal	O
exons	O
.	O

A	O
total	O
of	O
145,613	O
(	O
90	O
%	O
of	O
total	O
)	O
conserved	O
internal	O
exons	O
were	O
constitutive	O
exons	O
,	O
13,653	O
exons	O
(	O
8	O
%	O
)	O
had	O
evidence	O
of	O
exon	O
-	O
skipping	O
,	O
1,576	O
exons	O
were	O
mutually	O
exclusive	O
alternative	O
events	O
,	O
5,818	O
exons	O
had	O
alternative	O
3′	O
splice	O
sites	O
,	O
5,046	O
exons	O
had	O
alternative	O
5′	O
splice	O
sites	O
,	O
and	O
168	O
exons	O
overlapped	O
another	O
exon	O
.	O

Exon	O
array	O
analysis	O
.	O

The	O
Affymetrix	O
Power	O
Tools	O
(	O
APT	O
)	O
suite	O
of	O
programs	O
was	O
obtained	O
from	O
http://www.affymetrix.com/support/developer/powertools/index.affx	O
.	O

Exon	O
(	O
probeset	O
)	O
and	O
gene	O
-	O
level	O
signal	O
estimates	O
were	O
derived	O
from	O
the	O
CEL	O
files	O
by	O
RMA	O
–	O
sketch	O
normalization	O
as	O
a	O
method	O
in	O
the	O
apt	O
-	O
probeset	O
-	O
summarize	O
program	O
.	O

To	O
determine	O
if	O
the	O
signal	O
intensity	O
for	O
a	O
given	O
probeset	O
is	O
above	O
the	O
expected	O
level	O
of	O
background	O
noise	O
,	O
we	O
utilized	O
the	O
DABG	O
(	O
detection	O
above	O
background	O
)	O
quantification	O
method	O
available	O
in	O
the	O
apt	O
-	O
probeset	O
-	O
summarize	O
program	O
as	O
part	O
of	O
Affymetrix	O
Power	O
Tools	O
(	O
APT	O
)	O
.	O

Briefly	O
,	O
DABG	O
compared	O
the	O
signal	O
for	O
each	O
probe	O
to	O
a	O
background	O
distribution	O
of	O
signals	O
from	O
anti	O
-	O
genomic	O
probes	O
with	O
the	O
same	O
GC	O
content	O
.	O

The	O
DABG	O
algorithm	O
generated	O
a	O
p	O
-	O
value	O
representing	O
the	O
probability	O
that	O
the	O
signal	O
intensity	O
of	O
a	O
given	O
probe	O
was	O
part	O
of	O
the	O
background	O
distribution	O
.	O

We	O
considered	O
a	O
probeset	O
with	O
a	O
DABG	O
p	O
-	O
value	O
lower	O
than	O
0.05	O
as	O
detected	O
above	O
background	O
.	O

The	O
statistic	O
thCNS	O
-	O
SCns	O
,	O
ESC	O
=	O
(	O
μhCNS	O
-	O
SCns	O
−	O
μESC	O
)	O
/	O
sqrt	O
(	O
(	O
(	O
nhCNS	O
-	O
SCns	O
−	O
1	O
)	O
σ2hCNS	O
-	O
SCns	O
+	O
(	O
nESC	O
−	O
1	O
)	O
σ2ESC	O
)	O
(	O
nhCNS	O
-	O
SCns	O
+	O
nESC	O
)	O
)	O
/	O
(	O
(	O
nhCNS	O
-	O
SCnsnESC	O
)	O
(	O
nhCNS	O
-	O
SCns	O
+	O
nESC	O
−	O
2	O
)	O
)	O
)	O
,	O
where	O
nhCNS	O
-	O
SCns	O
and	O
nESC	O
were	O
the	O
number	O
of	O
replicates	O
,	O
μhCNS	O
-	O
SCns	O
and	O
μESC	O
were	O
the	O
mean	O
,	O
and	O
σ2hCNS	O
-	O
SCns	O
and	O
σ2ESC	O
were	O
the	O
variances	O
of	O
the	O
expression	O
values	O
for	O
the	O
two	O
datasets	O
used	O
to	O
represent	O
the	O
differential	O
enrichment	O
of	O
a	O
gene	O
using	O
gene	O
-	O
level	O
estimates	O
in	O
hCNS	O
-	O
SCns	O
relative	O
to	O
hESCs	O
.	O

Multiple	O
hypothesis	O
testing	O
was	O
corrected	O
by	O
controlling	O
for	O
the	O
false	O
discovery	O
rate	O
(	O
Benjamini	O
-	O
Hochberg	O
)	O
.	O

AS	O
detection	O
by	O
REAP.The	O
log2	O
signal	O
estimate	O
xij	O
for	O
probeset	O
i	O
in	O
cell	O
-	O
type	O
j	O
had	O
to	O
satisfy	O
two	O
conditions	O
,	O
otherwise	O
the	O
probeset	O
was	O
discarded	O
:	O
(	O
i	O
)	O
2	O
<	O
xij	O
<	O
10,000	O
for	O
all	O
conditions	O
/	O
cell	O
-	O
types	O
j	O
;	O
and	O
(	O
ii	O
)	O
DABG	O
p	O
-	O
value	O
<	O
0.05	O
for	O
all	O
replicates	O
in	O
at	O
least	O
one	O
condition	O
/	O
cell	O
-	O
type	O
j.	O
A	O
gene	O
had	O
to	O
have	O
five	O
probesets	O
that	O
satisfied	O
the	O
two	O
conditions	O
above	O
in	O
order	O
to	O
be	O
considered	O
for	O
robust	O
regression	O
analysis	O
.	O

After	O
generating	O
the	O
points	O
(	O
as	O
described	O
in	O
the	O
Results	O
section	O
)	O
,	O
we	O
utilized	O
the	O
robust	O
regression	O
method	O
rlm	O
in	O
R	O
-	O
package	O
""""	O
MASS	O
""""	O
(	O
version	O
6.1–2	O
)	O
with	O
M	O
-	O
estimation	O
and	O
a	O
maximum	O
iteration	O
setting	O
of	O
30	O
to	O
estimate	O
the	O
linear	O
function	O
yi	O
=	O
αxi	O
+	O
β	O
.	O

For	O
each	O
probeset	O
,	O
we	O
computed	O
the	O
error	O
term	O
ei	O
,	O
,	O
which	O
was	O
the	O
difference	O
between	O
the	O
actual	O
value	O
yi	O
and	O
the	O
estimated	O
value	O
ξi	O
,	O
from	O
the	O
estimated	O
function	O
ξi	O
=	O
Axi	O
+	O
B	O
,	O
where	O
A	O
and	O
B	O
were	O
estimates	O
of	O
α	O
and	O
β	O
.	O

The	O
error	O
term	O
variance	O
was	O
estimated	O
by	O
se2	O
=	O
Σei2	O
/	O
(	O
n	O
−	O
p	O
)	O
,	O
which	O
was	O
used	O
to	O
estimate	O
the	O
variance	O
of	O
the	O
predicted	O
value	O
,	O
sξi2	O
=	O
se2	O
(	O
n−1	O
+	O
(	O
xi	O
−	O
μx	O
)	O
2	O
/	O
sx2	O
(	O
n	O
−	O
1	O
)	O
)	O
.	O

Here	O
,	O
n	O
referred	O
to	O
the	O
number	O
of	O
points	O
(	O
generated	O
for	O
each	O
gene	O
)	O
,	O
and	O
p	O
referred	O
to	O
the	O
number	O
of	O
independent	O
variables	O
(	O
p	O
=	O
2	O
in	O
our	O
method	O
)	O
;	O
and	O
μx	O
=	O
Σxi2	O
/	O
n	O
;	O
sx2	O
=	O
n−1	O
Σ	O
(	O
xi	O
−	O
μx	O
)	O
2	O
.	O

Following	O
Belsley	O
et	O
al.	O
[	O
81	O
]	O
,	O
we	O
defined	O
the	O
leverage	O
hi	O
of	O
the	O
ith	O
point	O
as	O
hi	O
=	O
n−1	O
+	O
(	O
xi	O
−	O
μx	O
)	O
2	O
/	O
sx2	O
(	O
n	O
−	O
1	O
)	O
.	O

Here	O
we	O
considered	O
a	O
point	O
to	O
have	O
high	O
leverage	O
if	O
hi	O
>	O
3p	O
/	O
n	O
.	O

Next	O
,	O
we	O
calculated	O
the	O
covariance	O
ratio	O
,	O
covi	O
=	O
(	O
si2	O
/	O
sr2	O
)	O
p	O
/	O
(	O
1	O
−	O
hi	O
)	O
,	O
which	O
is	O
the	O
ratio	O
of	O
the	O
determinant	O
of	O
the	O
covariance	O
matrix	O
after	O
deleting	O
the	O
ith	O
observation	O
to	O
the	O
determinant	O
of	O
the	O
covariance	O
matrix	O
with	O
the	O
entire	O
sample	O
.	O

We	O
considered	O
a	O
point	O
to	O
have	O
high	O
influence	O
if	O
|covi	O
−	O
1|	O
>	O
3p	O
/	O
n	O
.	O

Lastly	O
,	O
we	O
computed	O
the	O
studentized	O
residuals	O
,	O
rstudenti	O
=	O
ei	O
/	O
(	O
s	O
(	O
i	O
)	O
2	O
(	O
1	O
−	O
hi	O
)	O
0.5	O
)	O
,	O
where	O
s	O
(	O
i	O
)	O
2	O
=	O
(	O
n	O
-	O
p	O
)	O
se2	O
/	O
(	O
n	O
-	O
p-1	O
)	O
–	O
ei2	O
/	O
(	O
n	O
-	O
p-1	O
)	O
(	O
1	O
−	O
hi	O
)	O
,	O
the	O
error	O
term	O
variance	O
after	O
deleting	O
the	O
ith	O
point	O
.	O

As	O
rstudenti	O
was	O
distributed	O
as	O
Student	O
's	O
t	O
-	O
distribution	O
with	O
n	O
-	O
p-1	O
degrees	O
of	O
freedom	O
,	O
each	O
rstudenti	O
value	O
was	O
associated	O
with	O
a	O
p	O
-	O
value	O
.	O

We	O
considered	O
a	O
point	O
to	O
be	O
an	O
""""	O
outlier	O
""""	O
if	O
p	O
<	O
0.01	O
.	O

Identification	O
of	O
motifs	O
.	O

The	O
enrichment	O
score	O
of	O
a	O
sequence	O
element	O
of	O
length	O
k	O
(	O
k	O
-	O
mer	O
)	O
in	O
one	O
set	O
of	O
sequences	O
(	O
set	O
1	O
)	O
versus	O
another	O
set	O
of	O
sequences	O
(	O
set	O
2	O
)	O
was	O
represented	O
by	O
the	O
nonparametric	O
χ2	O
statistic	O
with	O
Yates	O
correction	O
,	O
computed	O
from	O
the	O
two	O
by	O
two	O
contingency	O
table	O
,	O
T	O
(	O
T11	O
:	O
number	O
of	O
occurrences	O
of	O
the	O
element	O
in	O
set	O
1	O
;	O
T12	O
:	O
number	O
of	O
occurrences	O
of	O
all	O
other	O
elements	O
of	O
similar	O
length	O
in	O
set	O
1	O
;	O
T21	O
:	O
number	O
of	O
occurrences	O
of	O
element	O
in	O
set	O
2	O
;	O
T22	O
:	O
number	O
of	O
occurrences	O
of	O
all	O
other	O
elements	O
of	O
similar	O
length	O
in	O
set	O
2	O
.	O

All	O
elements	O
had	O
to	O
be	O
greater	O
than	O
5	O
.	O

To	O
correct	O
for	O
multiple	O
hypothesis	O
testing	O
,	O
p	O
-	O
values	O
were	O
multiplied	O
by	O
the	O
total	O
number	O
of	O
comparisons	O
.	O

